<?xml version='1.0' encoding='UTF-8'?>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article">
  <?properties open_access?>
  <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
    <restricted-by>pmc</restricted-by>
  </processing-meta>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Front Med (Lausanne)</journal-id>
      <journal-id journal-id-type="iso-abbrev">Front Med (Lausanne)</journal-id>
      <journal-id journal-id-type="publisher-id">Front. Med.</journal-id>
      <journal-title-group>
        <journal-title>Frontiers in Medicine</journal-title>
      </journal-title-group>
      <issn pub-type="epub">2296-858X</issn>
      <publisher>
        <publisher-name>Frontiers Media S.A.</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">35047525</article-id>
      <article-id pub-id-type="pmc">8761802</article-id>
      <article-id pub-id-type="doi">10.3389/fmed.2021.775344</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Medicine</subject>
          <subj-group>
            <subject>Original Research</subject>
          </subj-group>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Tai Chi Improves Brain Functional Connectivity and Plasma Lysophosphatidylcholines in Postmenopausal Women With Knee Osteoarthritis: An Exploratory Pilot Study</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Shen</surname>
            <given-names>Chwan-Li</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref>
          <xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref>
          <xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref>
          <xref rid="c001" ref-type="corresp">
<sup>*</sup>
</xref>
          <uri xlink:href="http://loop.frontiersin.org/people/96468/overview"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Watkins</surname>
            <given-names>Bruce A.</given-names>
          </name>
          <xref rid="aff4" ref-type="aff">
<sup>4</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kahathuduwa</surname>
            <given-names>Chanaka</given-names>
          </name>
          <xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref>
          <xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref>
          <xref rid="aff5" ref-type="aff">
<sup>5</sup>
</xref>
          <xref rid="aff6" ref-type="aff">
<sup>6</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Chyu</surname>
            <given-names>Ming-Chien</given-names>
          </name>
          <xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref>
          <xref rid="aff7" ref-type="aff">
<sup>7</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Zabet-Moghaddam</surname>
            <given-names>Masoud</given-names>
          </name>
          <xref rid="aff8" ref-type="aff">
<sup>8</sup>
</xref>
          <uri xlink:href="http://loop.frontiersin.org/people/1160412/overview"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Elmassry</surname>
            <given-names>Moamen M.</given-names>
          </name>
          <xref rid="aff9" ref-type="aff">
<sup>9</sup>
</xref>
          <xref rid="fn002" ref-type="author-notes">
<sup>†</sup>
</xref>
          <uri xlink:href="http://loop.frontiersin.org/people/858384/overview"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Luk</surname>
            <given-names>Hui-Ying</given-names>
          </name>
          <xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref>
          <xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref>
          <xref rid="aff10" ref-type="aff">
<sup>10</sup>
</xref>
          <uri xlink:href="http://loop.frontiersin.org/people/1493239/overview"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Brismée</surname>
            <given-names>Jean-Michel</given-names>
          </name>
          <xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref>
          <xref rid="aff11" ref-type="aff">
<sup>11</sup>
</xref>
          <uri xlink:href="http://loop.frontiersin.org/people/1477508/overview"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Knox</surname>
            <given-names>Ami</given-names>
          </name>
          <xref rid="aff12" ref-type="aff">
<sup>12</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lee</surname>
            <given-names>Jaehoon</given-names>
          </name>
          <xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref>
          <xref rid="aff13" ref-type="aff">
<sup>13</sup>
</xref>
          <uri xlink:href="http://loop.frontiersin.org/people/649020/overview"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Zumwalt</surname>
            <given-names>Mimi</given-names>
          </name>
          <xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref>
          <xref rid="aff14" ref-type="aff">
<sup>14</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>Rui</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Wager</surname>
            <given-names>Tor D.</given-names>
          </name>
          <xref rid="aff15" ref-type="aff">
<sup>15</sup>
</xref>
          <uri xlink:href="http://loop.frontiersin.org/people/50986/overview"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Neugebauer</surname>
            <given-names>Volker</given-names>
          </name>
          <xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref>
          <xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref>
          <xref rid="aff16" ref-type="aff">
<sup>16</sup>
</xref>
          <xref rid="aff17" ref-type="aff">
<sup>17</sup>
</xref>
          <uri xlink:href="http://loop.frontiersin.org/people/127949/overview"/>
        </contrib>
      </contrib-group>
      <aff id="aff1"><sup>1</sup><institution>Department of Pathology, Texas Tech University Health Sciences Center</institution>, <addr-line>Lubbock, TX</addr-line>, <country>United States</country></aff>
      <aff id="aff2"><sup>2</sup><institution>Center of Excellence for Integrative Health, Texas Tech University Health Sciences Center</institution>, <addr-line>Lubbock, TX</addr-line>, <country>United States</country></aff>
      <aff id="aff3"><sup>3</sup><institution>Center of Excellence for Translational Neuroscience and Therapeutics, Texas Tech University Health Sciences Center</institution>, <addr-line>Lubbock, TX</addr-line>, <country>United States</country></aff>
      <aff id="aff4"><sup>4</sup><institution>Department of Nutrition, University of California, Davis</institution>, <addr-line>Davis, CA</addr-line>, <country>United States</country></aff>
      <aff id="aff5"><sup>5</sup><institution>Department of Laboratory Sciences and Primary Care, Texas Tech University Health Sciences Center</institution>, <addr-line>Lubbock, TX</addr-line>, <country>United States</country></aff>
      <aff id="aff6"><sup>6</sup><institution>Department of Psychiatry, Texas Tech University Health Sciences Center</institution>, <addr-line>Lubbock, TX</addr-line>, <country>United States</country></aff>
      <aff id="aff7"><sup>7</sup><institution>Department of Medical Engineering, Texas Tech University</institution>, <addr-line>Lubbock, TX</addr-line>, <country>United States</country></aff>
      <aff id="aff8"><sup>8</sup><institution>Center for Biotechnology and Genomics, Texas Tech University</institution>, <addr-line>Lubbock, TX</addr-line>, <country>United States</country></aff>
      <aff id="aff9"><sup>9</sup><institution>Department of Biological Sciences, Texas Tech University</institution>, <addr-line>Lubbock, TX</addr-line>, <country>United States</country></aff>
      <aff id="aff10"><sup>10</sup><institution>Department of Kinesiology and Sport Management, Texas Tech University</institution>, <addr-line>Lubbock, TX</addr-line>, <country>United States</country></aff>
      <aff id="aff11"><sup>11</sup><institution>Department of Rehabilitation Sciences, Texas Tech University Health Sciences Center</institution>, <addr-line>Lubbock, TX</addr-line>, <country>United States</country></aff>
      <aff id="aff12"><sup>12</sup><institution>Clinical Research Institute, Texas Tech University Health Sciences Center</institution>, <addr-line>Lubbock, TX</addr-line>, <country>United States</country></aff>
      <aff id="aff13"><sup>13</sup><institution>Department of Educational Psychology and Leadership, Texas Tech University</institution>, <addr-line>Lubbock, TX</addr-line>, <country>United States</country></aff>
      <aff id="aff14"><sup>14</sup><institution>Department of Orthopedic Surgery, Texas Tech University Health Sciences Center</institution>, <addr-line>Lubbock, TX</addr-line>, <country>United States</country></aff>
      <aff id="aff15"><sup>15</sup><institution>Department of Psychological and Brain Sciences, Dartmouth College</institution>, <addr-line>Hanover, NH</addr-line>, <country>United States</country></aff>
      <aff id="aff16"><sup>16</sup><institution>Department of Pharmacology and Neuroscience, Texas Tech University Health Sciences Center</institution>, <addr-line>Lubbock, TX</addr-line>, <country>United States</country></aff>
      <aff id="aff17"><sup>17</sup><institution>Garrison Institute on Aging, Texas Tech University Health Sciences Center</institution>, <addr-line>Lubbock, TX</addr-line>, <country>United States</country></aff>
      <author-notes>
        <fn fn-type="edited-by">
          <p>Edited by: Georgios Filippou, Luigi Sacco University Hospital, Italy</p>
        </fn>
        <fn fn-type="edited-by">
          <p>Reviewed by: Yue Victor Zhang, Shenzhen Futian Hospital for Rheumatic Diseases, China; Feng Yang, Georgia State University, United States</p>
        </fn>
        <corresp id="c001">*Correspondence: Chwan-Li Shen <email>leslie.shen@ttuhsc.edu</email></corresp>
        <fn fn-type="other" id="fn001">
          <p>This article was submitted to Rheumatology, a section of the journal Frontiers in Medicine</p>
        </fn>
        <fn fn-type="present-address" id="fn002">
          <p>†Present address: Moamen M. Elmassry, Department of Molecular Biology, Princeton University, Princeton, NJ, United States</p>
        </fn>
      </author-notes>
      <pub-date pub-type="epub">
        <day>03</day>
        <month>1</month>
        <year>2022</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2021</year>
      </pub-date>
      <volume>8</volume>
      <elocation-id>775344</elocation-id>
      <history>
        <date date-type="received">
          <day>13</day>
          <month>9</month>
          <year>2021</year>
        </date>
        <date date-type="accepted">
          <day>15</day>
          <month>11</month>
          <year>2021</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright © 2022 Shen, Watkins, Kahathuduwa, Chyu, Zabet-Moghaddam, Elmassry, Luk, Brismée, Knox, Lee, Zumwalt, Wang, Wager and Neugebauer.</copyright-statement>
        <copyright-year>2022</copyright-year>
        <copyright-holder>Shen, Watkins, Kahathuduwa, Chyu, Zabet-Moghaddam, Elmassry, Luk, Brismée, Knox, Lee, Zumwalt, Wang, Wager and Neugebauer</copyright-holder>
        <license>
          <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
        </license>
      </permissions>
      <abstract>
        <p><bold>Objective:</bold> A pre/post pilot study was designed to investigate neurobiological mechanisms and plasma metabolites in an 8-week Tai-Chi (TC) group intervention in subjects with knee osteoarthritis.</p>
        <p><bold>Methods:</bold> Twelve postmenopausal women underwent Tai-Chi group exercise for 8 weeks (60 min/session, three times/week). Outcomes were measured before and after Tai Chi intervention including pain intensity (VAS), Brief Pain Inventory (BPI), Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), plasma metabolites (amino acids and lipids), as well as resting-state functional magnetic resonance imaging (rs-fMRI, 10 min, eyes open), diffusion tensor imaging (DTI, 12 min), and structural MRI (4.5 min) in a subgroup. Clinical data was analyzed using paired <italic toggle="yes">t</italic>-tests; plasma metabolites were analyzed using Wilcoxon signed-rank tests; and rs-fMRI data were analyzed using seed-based correlations of the left and right amygdala in a two-level mixed-effects model (FSL software). Correlations between amygdala-medial prefrontal cortex (mPFC) connectivity and corresponding changes in clinical outcomes were examined. DTI connectivity of each amygdala was modeled using a Bayesian approach and probabilistic tractography. The associations between neurobiological effects and pain/physical function were examined.</p>
        <p><bold>Results:</bold> Significant pre/post changes were observed with reduced knee pain (VAS with most pain: <italic toggle="yes">p</italic> = 0.018; WOMAC-pain: <italic toggle="yes">p</italic> = 0.021; BPI with worst level: <italic toggle="yes">p</italic> = 0.018) and stiffness (WOMAC-stiffness, <italic toggle="yes">p</italic> = 0.020), that likely contributed to improved physical function (WOMAC-physical function: <italic toggle="yes">p</italic> = 0.018) with TC. Moderate to large effect sizes pre/post increase in rs-fMRI connectivity were observed between bilateral mPFC and the amygdala seed regions (i.e., left: <italic toggle="yes">d</italic> = 0.988, <italic toggle="yes">p</italic> = 0.355; right: <italic toggle="yes">d</italic> = 0.600, <italic toggle="yes">p</italic> = 0.282). Increased DTI connectivity was observed between bilateral mPFC and left amygdala (<italic toggle="yes">d</italic> = 0.720, <italic toggle="yes">p</italic> = 0.156). There were moderate-high correlations (<italic toggle="yes">r</italic> = 0.28–0.60) between TC-associated pre-post changes in amygdala-mPFC functional connectivity and pain/physical function improvement. Significantly higher levels of lysophosphatidylcholines were observed after TC but lower levels of some essential amino acids. Amino acid levels (alanine, lysine, and methionine) were lower after 8 weeks of TC and many of the lipid metabolites were higher after TC. Further, plasma non-HDL cholesterol levels were lower after TC.</p>
        <p><bold>Conclusion:</bold> This pilot study showed moderate to large effect sizes, suggesting an important role that cortico-amygdala interactions related to TC have on pain and physical function in subjects with knee osteoarthritis pain. Metabolite analyses revealed a metabolic shift of higher lyso-lipids and lower amino acids that might suggest greater fatty acid catabolism, protein turnover and changes in lipid redistribution in response to TC exercise. The results also support therapeutic strategies aimed at strengthening functional and structural connectivity between the mPFC and the amygdala. Controlled clinical trials are warranted to confirm these observed preliminary effects.</p>
      </abstract>
      <kwd-group>
        <kwd>mind-body exercise</kwd>
        <kwd>neuroimaging</kwd>
        <kwd>pain</kwd>
        <kwd>metabolomics</kwd>
        <kwd>WOMAC</kwd>
      </kwd-group>
      <counts>
        <fig-count count="6"/>
        <table-count count="2"/>
        <equation-count count="0"/>
        <ref-count count="104"/>
        <page-count count="16"/>
        <word-count count="11728"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro" id="s1">
      <title>Introduction</title>
      <p>Knee osteoarthritis (OA), a progressive joint disease characterized by joint degeneration and inflammation (<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B2" ref-type="bibr">2</xref>), is one of the five leading causes of disability (<xref rid="B3" ref-type="bibr">3</xref>). Increasing evidence shows that more patients with knee OA pain consider complementary and alternative medicine (<xref rid="B4" ref-type="bibr">4</xref>) to mitigate pain and improve physical function (<xref rid="B5" ref-type="bibr">5</xref>). Among different forms of complementary alternative medicine (CAM), Tai Chi (TC), a mind-body moderate exercise, has shown to reduce knee OA pain, and improve physical function (<xref rid="B6" ref-type="bibr">6</xref>–<xref rid="B10" ref-type="bibr">10</xref>). These prior trials suggested that TC could provide a practical exercise regimen to manage knee OA. However, TC's mechanisms of action regarding improvement of one's clinical condition and its functional outcomes in individuals with knee OA are poorly understood.</p>
      <p>Chronic pain, such as knee OA, is associated with alterations in brain functions that modulate pain. Animal studies have shown that chronic pain is associated with increased activity of the amygdala, a brain region involved in modulating pain, emotional states, and addictive behaviors. Specifically, activity of basolateral (BLA) and central (CeA) nuclei of the amygdala increases in chronic pain (e.g., knee OA) (<xref rid="B11" ref-type="bibr">11</xref>, <xref rid="B12" ref-type="bibr">12</xref>). Conversely, deactivation of the medial prefrontal cortex (mPFC), a brain region involved in regulating executive control, has been shown in chronic pain conditions, possibly due to enhanced feed forward inhibition by the amygdala (<xref rid="B13" ref-type="bibr">13</xref>). Functional magnetic resonance imaging (fMRI) and diffusion tensor imaging (DTI) are non-invasive methods that rely on magnetic resonance imaging technology. fMRI and DTI have been used to examine the effects of conditions such as chronic pain in the human brain (<xref rid="B14" ref-type="bibr">14</xref>–<xref rid="B17" ref-type="bibr">17</xref>). fMRI relies on temporal changes in oxygenated hemoglobin levels between regions of the brain to estimate the changes in functional activity between brain regions. Accordingly, temporal correlations of fMRI reactivity between brain regions serve as surrogates of functional connectivity between brain regions of interest. DTI utilizes the net rate of diffusion of water in a given direction to estimate structural (i.e., white matter) connectivity between brain regions. Taken together, resting state fMRI (rs-fMRI) and DTI allows examination of functional and structural connectivity (or neural interactions linking brain regions) between brain regions of interest in patients suffering from chronic pain.</p>
      <p>fMRI has been used to study pain sensitization in knee OA patients (<xref rid="B14" ref-type="bibr">14</xref>–<xref rid="B17" ref-type="bibr">17</xref>). Some recent studies that specifically examined the functional reactivity of the amygdala in chronic pain using rs-fMRI have concluded that the resting state functional reactivity as well as functional connectivity of the amygdala seems to be enhanced in chronic pain conditions (<xref rid="B18" ref-type="bibr">18</xref>, <xref rid="B19" ref-type="bibr">19</xref>). More importantly, structural connectivity in a circuit that includes the amygdala, mPFC, and the nucleus accumbens was found to be mediating the association between negative effects and the transition to chronic pain (<xref rid="B18" ref-type="bibr">18</xref>). This line of evidence for effects of chronic pain on functional and structural connectivity between the amygdala and mPFC corroborate results from animal experiments (<xref rid="B11" ref-type="bibr">11</xref>, <xref rid="B20" ref-type="bibr">20</xref>–<xref rid="B23" ref-type="bibr">23</xref>). As such, it is logical to speculate that chronic pain disrupts the functional and structural connectivity between the amygdala and mPFC.</p>
      <p>Adoption of metabolomics analysis to the study of OA has helped elucidate metabolic pathways and specific metabolite markers to advance the understanding of OA-caused metabolic shifts associated with systemic inflammation and oxidative stress (<xref rid="B24" ref-type="bibr">24</xref>–<xref rid="B27" ref-type="bibr">27</xref>). For instance, Zhang et al. found that compared to the non-OA subjects, the OA subjects had significantly higher concentration of acylcarnitines, but lower concentration of free carnitine in the synovial fluid, suggesting alterations in mitochondrial fatty acid oxidation in the OA status (<xref rid="B28" ref-type="bibr">28</xref>). Mickiewicz et al. corroborated with Zhang's study by identifying 11 metabolites in urine samples of OA subjects, but not in non-OA subjects, and authors concluded that these metabolites were mostly related to energy metabolism (<xref rid="B29" ref-type="bibr">29</xref>). In a case-control study, Abdelrazig et al. reported that compared to non-OA controls, knee OA subjects had altered urinary metabolic profiles that associated with perturbed activity of the TCA cycle, pyruvate, and amino acid metabolism which linked to inflammation, oxidative stress, and collagen destruction (<xref rid="B27" ref-type="bibr">27</xref>). Authors also showed that 2-keto-glutaramic acid level was at least 8-fold greater in the inflammatory OA patients than that in the non-OA control, suggesting a possible perturbation in glutamine metabolism related to OA progression (<xref rid="B27" ref-type="bibr">27</xref>).</p>
      <p>The metabolic pathways that affect amino acid metabolism and phospholipid metabolism have been reported to associate with OA progression (<xref rid="B24" ref-type="bibr">24</xref>). Tootsi et al. reported that OA patients had higher levels of arginine, asparagine, leucine, serine, asymmetric dimethylarginine, phenylalanine, and spermidine, and lower levels of serotonin and spermine/spermidine ratio in serum (<xref rid="B26" ref-type="bibr">26</xref>). The decreased spermine/spermidine ratio is indicative of excessive oxidative stress in OA patients (<xref rid="B26" ref-type="bibr">26</xref>). Moreover, Tootsi et al. reported the conversion pathway of phosphatidylchoine (PC) to lysophosphatidylcholine (LPC) is overactivated in OA patients, suggesting OA patients display greater level of systemic inflammation (<xref rid="B26" ref-type="bibr">26</xref>). However, the effects of TC on the levels of essential and gluconeogenic amino acids, and lipid metabolites in patients with knee OA are unknown.</p>
      <p>TC is reported to increase overall structural connectivity (i.e., white matter connectivity between two or more considered brain regions) as measured by brain DTI in elderly women (<xref rid="B30" ref-type="bibr">30</xref>). TC also improved rs-fMRI functional connectivity between the mPFC and the hippocampus in older adults (<xref rid="B31" ref-type="bibr">31</xref>). Thus, TC seems to increase both functional and structural connectivity of mPFC. However, the only rs-fMRI neuroimaging study that examined TC effects on brain connectivity in patients with knee OA, or any chronic pain condition, focused on the periaqueductal gray matter and ventral tegmental area. While this study demonstrated that exposure to 12-weeks of TC exercise reduced connectivity between ventral tegmental area and mPFC (<xref rid="B16" ref-type="bibr">16</xref>), the effects of TC on amygdala-mPFC interactions, which form a critical node for the processing of emotional and cognitive aspects of pain, has never been addressed. Therefore, we hypothesized that mind-body interventions such as TC may alleviate chronic pain by restoring connectivity in cortico-limbic circuits involving mPFC and the amygdala, because the mPFC as a center of the cognitive control network can modulate pain (<xref rid="B32" ref-type="bibr">32</xref>–<xref rid="B34" ref-type="bibr">34</xref>). Moreover, mind-body interventions can modulate connectivity in brain circuits centered on the mPFC (<xref rid="B35" ref-type="bibr">35</xref>), although pain modulation by mindfulness has been shown to occur independently of prefrontal cortical changes (<xref rid="B36" ref-type="bibr">36</xref>). Therefore, the objectives of this pilot study were to explore if after 8-weeks of TC exercise (i) resting state functional (i.e., rs-fMRI) and structural (i.e., DTI) connectivity between each amygdala and mPFC would increase among subjects with knee OA as compared to baseline, (ii) would modify plasma amino acid and lipid metabolites, and (iii) improve TC-associated pre-post changes between amygdala-mPFC functional connectivity and pain/physical function as well as between structural connectivity and pain/physical function. We hypothesized that 8-weeks of TC exercise would increase the amygdala-mPFC rs-fMRI and DTI connectivity of subjects with knee OA. Furthermore, TC would lead to changes in blood lipids, plasma metabolites, and lipid mediators of inflammation to improve well-being. Consistent with our hypothesis, we propose that TC changes in amygdala-mPFC rs-fMRI and DTI connectivity would correlate with reduced pain/stiffness and improved physical function.</p>
    </sec>
    <sec sec-type="materials and methods" id="s2">
      <title>Materials and Methods</title>
      <sec>
        <title>Study Design</title>
        <p>The present trial was based on a single group pre-test and post-test design to examine the effects of an 8-week TC exercise intervention on pain, physical function, stiffness, brain functional connectivity, and plasma metabolites including amino acids and lipids. Blood samples were collected at baseline and after 8 week of TC intervention. Plasma samples were stored at −80°C for later metabolites analysis. This study was approved by the Institutional Review Board at the Texas Tech University Health Sciences Center (<ext-link xlink:href="https://ClinicalTrials.gov" ext-link-type="uri">ClinicalTrials.gov</ext-link> Identifier: NCT04046003).</p>
      </sec>
      <sec>
        <title>Recruitment of Subjects</title>
        <p>Postmenopausal women &gt;50 years of age with knee pain were recruited from clinics and community centers by flyers and advertisements through newspaper. The prevalence of OA increases rapidly with age, beginning at about age 40–50 years in women, but less so in men. The hormone deficiency increases the risk of OA severity in postmenopausal women. Women older than 50 have a higher prevalence and are also more likely to report joint symptoms for the same level of radiographic severity in knee OA (<xref rid="B37" ref-type="bibr">37</xref>). Thus, in this study, the postmenopausal women were our target study population. If women reported bilateral symptomatic knees, only the most symptomatic knee was included in the study. Written informed consent was obtained from all subjects. Participants were selected based on the following including and excluding criteria. Inclusion criteria: (1) Postmenopausal women, (2) WOMAC pain score with at least two items out of five items are rated as moderate, severe, or extreme, respectively, (3) English literacy, (4) Able to undergo an MRI scan for subjects having MRIs, (5) current pain in the knee, and (6) medical diagnosis of knee OA or knee(s) exhibited symptoms based on American College of Rheumatology clinical classification criteria for OA (<xref rid="B38" ref-type="bibr">38</xref>). Exclusive criteria: (1) Prior experience with mind-body practice (e.g., TC, Qi Gong, yoga, or acupuncture) or physical therapy programs for knee OA within the past 3 months, (2) Severe medical limitations (i.e., dementia, symptomatic heart or vascular disease, or recent stroke) precluding full participation, (3) Medical/neurological or other systemic diseases affecting the musculoskeletal systems (i.e., polio/Parkinson's/multiple sclerosis, rheumatoid arthritis, uncontrolled gout, etc. in addition to cerebral vascular accident or stroke) and diabetes with peripheral neuropathy affecting their sensory/balance, (4) Intra-articular steroid injection or reconstructive surgery on most severely affected knee in the past 3 months, (5) Intra-articular hyaluronic acid injections on most severely affected knee in the past 6 months, and (6) Inability to walk without an assistive device.</p>
      </sec>
      <sec>
        <title>Tai Chi Intervention and Compliance</title>
        <p>The 24-form Yang style TC was employed in this study. The 24-form Yang style TC is one of the most widely practiced TC styles worldwide and one of the TC styles most widely adopted in clinical studies, with all movements well-standardized and publicized (<xref rid="B39" ref-type="bibr">39</xref>). The 8-week 24-form group TC program included instructed TC group classes three times per week on 3 non-consecutive days, 60 min each time at Gym of Department of Kinesiology and Sport Management, Texas Tech University, Lubbock (<xref rid="B40" ref-type="bibr">40</xref>, <xref rid="B41" ref-type="bibr">41</xref>). Compliance of TC classes was assessed by TC class attendance record for each TC session.</p>
        <p>Tai Chi was taught by a Master TC teacher for an 8-week period. This time selection was based on our previous studies that evaluated patients with knee OA and the effects of TC on various parameters including pain, function, range of motion, and gait parameters in 6- to 12-week trials (<xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B42" ref-type="bibr">42</xref>). The TC instructor and his assistant paid close attention to each participant during every class and made sure everyone performs TC correctly within 8 weeks. Based on our previous TC studies, all participants were able to perform the 24-form Yang style TC by themselves after 1 month. We have demonstrated in a previous study that we can teach TC and show positive effects in a group of OA participants in an even shorter period - 6 weeks (<xref rid="B6" ref-type="bibr">6</xref>). However, participants may subjectively expect that the intervention (Tai Chi) can improve pain, and reflect this in the subjective outcome measures (i.e., surveys), partly to please the researcher. Thus, the Hawthorne effect may be a confounder to the surveys, although not for the objective measures (e.g., fMRI, blood tests).</p>
      </sec>
      <sec>
        <title>Measurement of Pain, Physical Function, and Stiffness</title>
        <p>The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) questionnaire was used with a scale from 26 (no difficulty) to 130 (extreme difficulty) indicating the level of difficulty associated with overall functional activities due to knee pain, including subscale of knee pain (35 points), stiffness (10 points), and physical function (85 points) (<xref rid="B6" ref-type="bibr">6</xref>). Pain was assessed using WOMAC-pain subscale (<xref rid="B6" ref-type="bibr">6</xref>), visual analog scale (VAS) (<xref rid="B6" ref-type="bibr">6</xref>), and Brief Pain Inventory (BPI)-pain scale (<xref rid="B43" ref-type="bibr">43</xref>). The BPI is a validated self-reported questionnaire that assesses pain severity using the Numerical Rating Scale for Pain Intensity (NRS-PI, 0–10 scale, where 0 = no pain and 10 = worst possible pain) for the conditions of worst, least, and average pain, as well as “pain right now” (<xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B43" ref-type="bibr">43</xref>). Physical function was assessed using WOMAC-physical function and WOMAC-stiffness subscales (<xref rid="B6" ref-type="bibr">6</xref>) as well as BPI-interference scale (<xref rid="B43" ref-type="bibr">43</xref>). These measures, WOMAC (<xref rid="B44" ref-type="bibr">44</xref>), VAS, and BPI (<xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B45" ref-type="bibr">45</xref>), are commonly used in knee OA studies with good validity, internal consistency, and reliability.</p>
      </sec>
      <sec>
        <title>Measurement of Plasma Lipids</title>
        <p>Laboratory lipid panel including total cholesterol, triglycerides, high-density lipoprotein (HDL)-cholesterol, non-HDL cholesterol, low-density lipoprotein (LDL)-cholesterol, very low-density lipoprotein (VLDL)-cholesterol, and Cholesterol/HDL ratio were assessed in plasma samples taken at baseline and 8 weeks. All samples were processed and analyzed in a certified diagnostic laboratory (Covenant Laboratory, Lubbock, TX).</p>
      </sec>
      <sec>
        <title>Measurement of Plasma Amino Acids and Lipids Biochemicals</title>
        <p>The levels of metabolites in the plasma were determined using the AbsoluteIDQ™ p400 HR kit (BIOCRATES Life Sciences AG, Innsbruck, Austria) according to the manufacturer's instructions at the Center for Biotechnology &amp; Genomics, Texas Tech University, Lubbock, TX. This assay allows the identification and quantification of more than 400 endogenous metabolites including 21 amino acids, 21 biogenic amines, 55 acylcarnitines, 18 diglycerides, 42 triglycerides, 24 LPC, 172 PC, 31 sphingomyelins, ceramides, and 14 cholesteryl esters. Identification and quantification of the metabolites was done using multiple reaction monitoring according to internal standards. Samples were analyzed by Q Exactive HF mass spectrometer coupled with a Vanquish ultra-high performance liquid chromatography (UHPLC) system (Thermo Scientific, USA). The amino acids and biogenic amines were separated using UHPLC with a C18 column (Biocrates, Part 9120052121032). Analytes were separated using a total 6 min gradient from solvent A (0.2% formic acid in water, to 95% Solvent B (0.2% formic acid in acetonitrile) per sample.</p>
        <p>For lipid analyses, acylcarnitines, monosaccharides (hexose), diglycerides, triglycerides, LPC, PC, sphingomyelins, ceramides, and cholesteryl esters were analyzed by flow injection analysis (FIA) with total analysis time of ~3.8 min per sample with specific FIA mobile phase buffer (Part 9120052121018) provided in the kit, which was diluted into LC–MS grade methanol for use with the kit per manufacturer instructions. Using electrospray ionization in positive ion mode, samples for both UHPLC and flow injection analysis were introduced directly into Q Exactive Orbitrap MS systems (Thermo Fisher Scientific, Waltham, MA, USA) operating in the full scan or parallel reaction monitoring (PRM) mode. Acquisition methods and tune parameters for all instruments were provided by Biocrates as part of the p400HR kit. The concentrations of metabolites were calculated in μM. The LC–MS data were imported into the QuanBrowser module of the Thermo Xcalibur software (Thermo Fischer Scientific) for peak integration and quantification, then imported into MetIDQ<sup>TM</sup> software package (Biocrates AG).</p>
      </sec>
      <sec>
        <title>Measurement of Brain Connectivity</title>
        <p>MRI scans were performed pre-and post-intervention with the intention of modeling the resting state functional connectivity (as measured using temporal correlations between the regions) as well structural connectivity (as modeled using diffusion parameters of water in the brain) between left and right amygdala and the mPFC. Each participant underwent two MRI scanning sessions scheduled pre- and post-intervention (0 and 12 weeks, respectively). All MRI scans were performed using a 3.0 T Siemens Skyra scanner with a 20-channel head coil located at Texas Tech Neuroimaging Institute, Lubbock, TX. Each scanning session included a scout MRI scan; an rs-fMRI scan (10 min) conducted while participants kept their eyes open; a DTI scan (12 min) and a T-weighted structural MRI scan (4.5 min). Rs-fMRI data were acquired using an echo planar imaging sequence with the following parameter settings: repetition time = 3,000 ms; echo time = 30 ms; flip angle = 90; field of view = 220 mm; matrix = 64 × 64; slice thickness = 3.4 mm; and 48 ascending axial slices. Slices were tilted ~30° from the anterior commissure—posterior commissure line to minimize orbitofrontal cortical signal dropout. Diffusion weighted images were acquired using a spin-echo-based EPI sequence with the following parameters: repetition time = 10,200 ms; echo time = 82 ms; field of view = 250 mm; matrix = 125 × 125; slice thickness = 2 mm; and 80 contiguous axial slices (a non-diffusion weighted image at b = 0 s/mm<sup>2</sup> and 62 volumes with uniformly distributed diffusion gradient directions at b = 1,000 s/mm<sup>2</sup>). The structural scan was performed using the following parameters: repetition time = 2,300 ms; echo time = 2.96 ms; flip angle = 9; field of view = 256 mm; matrix = 256 × 256; slice thickness = 1.2 mm; and 176 slices.</p>
      </sec>
      <sec>
        <title>Data Processing and Statistical Analysis</title>
        <p>Descriptive statistics were calculated to inspect the distributional properties of pain, physical function, stiffness, blood lipids, and plasma metabolites. In addition, parametric and non-parametric tests were performed to examine the changes between pre- and post-intervention—paired-samples <italic toggle="yes">t</italic>-test for pain, physical function, and stiffness parameters and Wilcoxon signed-rank test for metabolite parameters. Prior to analysis, normality of pain and lipid outcomes was confirmed by skewness of the distributions (−0.80 to 1.50 at pre-intervention; 0.47–2.64 at post-intervention), as well as visual inspection of the Q-Q plots. The fMRI-related outcomes were normalized by using a Gaussian kernel. For pain, lipid, and metabolite outcomes, statistical significance was determined at an alpha level adjusted for multiple comparisons (i.e., Benjamin-Hochberg adjustment), and an effect size was computed for each comparison. All analyses were conducted using R (<xref rid="B46" ref-type="bibr">46</xref>).</p>
        <p>Structural, resting-state functional and diffusion weighted raw data images were converted to NIfTI format using the dcm2nii converter (<xref rid="B47" ref-type="bibr">47</xref>). Structural images were pre-processed using Freesurfer (autorecon1) (<xref rid="B48" ref-type="bibr">48</xref>, <xref rid="B49" ref-type="bibr">49</xref>). Functional images were preprocessed using tools in the FMRIB Software Library (FSL; Version 6.00, Oxford, UK). The following pre-processing steps were applied: motion correction by aligning each functional volume to the center volume within each functional run with 6-degrees of freedom (DOF) sinc interpolation using FSL's MCFLIRT tool (<xref rid="B50" ref-type="bibr">50</xref>); skull-stripping using FSL's BET tool (<xref rid="B51" ref-type="bibr">51</xref>); registration to high resolution structural space by the BBR algorithm and subsequently to the standard space by 12-DOF using FSL's FLIRT tool (<xref rid="B52" ref-type="bibr">52</xref>); spatial smoothing using a Gaussian kernel of FWHM 8.0 mm; grand-mean intensity normalization of the entire 4D dataset by a single multiplicative factor; high-pass temporal filtering (Gaussian-weighted least-squares straight line fitting, with sigma = 50.0 s); and FILM pre-whitening (<xref rid="B53" ref-type="bibr">53</xref>).</p>
        <p>Resting-state fMRI data were analyzed using seed-based correlations. For the analyses, probability masks of each of left and right amygdala regions were created (<xref rid="B54" ref-type="bibr">54</xref>–<xref rid="B59" ref-type="bibr">59</xref>) using the Harvard-Oxford subcortical structural atlas in FSL and were converted to functional space of each participant using the FNIRT tool in FSL (<xref rid="B60" ref-type="bibr">60</xref>). Time-course of each seed region of pre- and postintervention scan was extracted from the pre-processed data using the fslmeants command in FSL. Resting state fMRI data were analyzed using a standard two-level pipeline in FSL. In level 1 analyses, subject level correlations between each seed region's time series and rs-fMRI data of the entire brain were analyzed using the Feat tool in FSL. An autocorrelation correction was included to account for serial dependencies between samples Woolrich 2001 (<xref rid="B53" ref-type="bibr">53</xref>). Level 2 analyses were equivalents of paired <italic toggle="yes">t</italic>-tests comparing the pre- vs. post-intervention level 1 estimates for each seed region (i.e., left or right amygdala). Considering the exploratory nature of the study and the limited sample size, the analyses were performed using ordinary least squares (i.e., linear approach).</p>
        <p>Pain-associated functional dissociation of amygdala and the broader mPFC have been a consistent finding in both animal and human studies, however, there are some differences in specific sub-regions within the mPFC that showed functional dissociations. Generally, altered amygdala connectivity mainly with the infra- and pre-limbic mPFC, which are equivalent to Brodmann areas 25 and ventral 32 is reported in human subjects (<xref rid="B13" ref-type="bibr">13</xref>, <xref rid="B61" ref-type="bibr">61</xref>–<xref rid="B64" ref-type="bibr">64</xref>), while human fMRI studies reported dissociated connectivity of amygdala with ventromedial PFC, including Brodmann area 25 (<xref rid="B65" ref-type="bibr">65</xref>) and anterior and cingulate cortical regions representing Brodmann areas dorsal 24 and 25 (<xref rid="B64" ref-type="bibr">64</xref>). To address potential challenges in translating the preclinical brain connectivity pattern to the human brain, we searched for clusters showing intervention-related alterations of functional connectivity with amygdala within broader target regions of mPFC (defined using a mask combing the frontal medial cortex, subcallosal cortex, paracingulate cortex and anterior cingulate cortex using Harvard-Oxford Subcortical Structural Atlas in FSL) representing Brodmann areas 32, 25, 24, and 33. Final statistical maps were thresholded using this broad mPFC mask for a z-threshold of 1.96 corresponding to a FWER corrected <italic toggle="yes">p</italic>-value of 0.05. Irrespective of the outcomes of the primary analyses, subject-level contrasts of parameter estimates of the mPFC of each level 1 analysis were extracted using the featquery tool in FSL (<xref rid="B66" ref-type="bibr">66</xref>). These contrasts of parameter estimates were used to calculate effect sizes. Furthermore, Spearman correlation analyses were performed using these parameter estimates between pre- vs. post-intervention changes in amygdala-mPFC functional connectivity and the corresponding changes in behavioral measures (i.e., VAS, WOMAC, and BPI) using R statistical software (4.0.2). fMRI data of one participant had to be excluded from the effect-size calculations and correlation analyses due to the contrasts of parameter estimates of both pre- and post-intervention scans being zero.</p>
        <p>DTI data were subjected to distortion correction and brain extraction and were subsequently corrected for eddy currents and head motion using tools in the FDT Toolbox in FSL (<ext-link xlink:href="http://fsl.fmrib.ox.ac.uk/fsl/fslwiki/FDT" ext-link-type="uri">http://fsl.fmrib.ox.ac.uk/fsl/fslwiki/FDT</ext-link>). The diffusion parameters of the images were estimated using a Bayesian approach (i.e., BEDPOSTX) in FSL (<xref rid="B67" ref-type="bibr">67</xref>, <xref rid="B68" ref-type="bibr">68</xref>). Waypoint network connectivity mapping was performed using probabilistic tractography (i.e., PROBTRACX) in FSL to estimate the connectivity between each amygdala and the mPFC which defined using Harvard Oxford Cortical and Subcortical Structural Atlases in FSL (<xref rid="B69" ref-type="bibr">69</xref>). While not ideal given the likelihood of regression of the post-intervention outcomes toward the mean (<xref rid="B70" ref-type="bibr">70</xref>), considering the pilot nature of the design and the limited sample size, pre-post comparisons of the extracted total structural connectivity were performed using Wilcoxon signed-rank tests in R statistical software (4.0.2) and the corresponding effect-sizes were calculated. Moreover, Spearman correlation analyses were performed between pre- vs. post-intervention changes in amygdala-mPFC functional connectivity and the corresponding changes in behavioral measures (i.e., VAS, WOMAC, and BPI) as well as multiple biochemical markers.</p>
      </sec>
    </sec>
    <sec sec-type="results" id="s3">
      <title>Results</title>
      <sec>
        <title>Participants</title>
        <p>A total of 42 participants were prescreened. Among them, 17 participants met the criteria and enrolled into the study. Five participants dropped from the study due to conflict of time (<italic toggle="yes">n</italic> = 1), loss of interest with low compliance (&lt;15%, <italic toggle="yes">n</italic> = 3), and steroid injection in knee during the study (<italic toggle="yes">n</italic> = 1). A total of 12 participants completed the 8-week study. All subjects were instructed to maintain their pre-existing physical activity, dietary habits, and medications, if any, throughout the study. A subgroup of participants (<italic toggle="yes">n</italic> = 7) received fMRI scanning for brain functional connectivity. Throughout the study, the compliance rate for TC classes was 93%. <xref rid="T1" ref-type="table">Table 1</xref> lists demographic characteristics and medical history of study participants.</p>
        <table-wrap position="float" id="T1">
          <label>Table 1</label>
          <caption>
            <p>Demographic characteristics of study population.</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th valign="top" align="left" rowspan="1" colspan="1">
<bold>Variables</bold>
</th>
                <th valign="top" align="center" rowspan="1" colspan="1">
<bold>Subjects (<italic toggle="yes">n</italic> = 12)</bold>
</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Age [y]</td>
                <td valign="top" align="center" rowspan="1" colspan="1">64.5 ± 6.7</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Weight [kg]</td>
                <td valign="top" align="center" rowspan="1" colspan="1">82.5 ± 10.2</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Height [cm]</td>
                <td valign="top" align="center" rowspan="1" colspan="1">164.3 ± 6.3</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Body mass index [kg/m<sup>2</sup>]</td>
                <td valign="top" align="center" rowspan="1" colspan="1">30.6 ± 4.1</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Regular physical activities [<italic toggle="yes">n</italic> (%)]</td>
                <td valign="top" align="center" rowspan="1" colspan="1">9 (75)</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">    Low (walking, gardening)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">4 (44.4)</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">    Medium (bicycling, swimming)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">5 (55.6)</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">    High (aerobic, running)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0 (0)</td>
              </tr>
              <tr>
                <td valign="top" align="left" colspan="2" rowspan="1">Medical history questions [<italic toggle="yes">n</italic> (%)]</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">    General health rated “good”</td>
                <td valign="top" align="center" rowspan="1" colspan="1">12 (100)</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">    Total knee replacement</td>
                <td valign="top" align="center" rowspan="1" colspan="1">2 (16.7)</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">    History of rheumatoid arthritis or gout</td>
                <td valign="top" align="center" rowspan="1" colspan="1">1 (8.3)</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">    Heart value/cardiac bypass surgery, stent procedure, or pacemaker</td>
                <td valign="top" align="center" rowspan="1" colspan="1">2 (16.7)</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">    History stroke or heart attack</td>
                <td valign="top" align="center" rowspan="1" colspan="1">1 (8.3)</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">    Low back pain and/or leg pain</td>
                <td valign="top" align="center" rowspan="1" colspan="1">2 (16.7)</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">    Hormone or hormone-like therapy use</td>
                <td valign="top" align="center" rowspan="1" colspan="1">2 (16.7)</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">    Blood pressure drug use</td>
                <td valign="top" align="center" rowspan="1" colspan="1">3 (25)</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">    Thyroid hormone drug use</td>
                <td valign="top" align="center" rowspan="1" colspan="1">2 (16.7)</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">    Pain medication use</td>
                <td valign="top" align="center" rowspan="1" colspan="1">4 (33.4)</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">    Calcium/vitamin D use</td>
                <td valign="top" align="center" rowspan="1" colspan="1">6 (50)</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">    History of cigarettes (current or ever-smoked)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">3 (25.0)</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">    Alcohol consumption</td>
                <td valign="top" align="center" rowspan="1" colspan="1">7 (58.3)</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <p><italic toggle="yes">All data are mean ± standard deviation unless otherwise specified</italic>.</p>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec>
        <title>Pain, Physical Function, and Stiffness</title>
        <p><xref rid="F1" ref-type="fig">Figure 1</xref> presents the effect of 8-week TC on pain, physical function, and stiffness. After 8-week TC exercise, subjects with knee OA had significant pain reduction in OA-affected knee as assessed by WOMAC-pain scale (<italic toggle="yes">p</italic> = 0.021), VAS with most pain (<italic toggle="yes">p</italic> = 0.018) and overall amount in the last week (<italic toggle="yes">p</italic> = 0.018) and right now (<italic toggle="yes">p</italic> = 0.068), and BPI with worst level (<italic toggle="yes">p</italic> = 0.018) and least amount (<italic toggle="yes">p</italic> = 0.033) in the past 24 h (<italic toggle="yes">p</italic> = 0.018). Compared to the baseline, after 8-week TC exercise, the subjects reported significantly reduced stiffness at OA-affected knee by 50%, as demonstrated by WOMAC-stiffness subscale (<italic toggle="yes">p</italic> = 0.020). In terms of physical function, after 8-week TC group exercise, the subjects significantly improved their physical function as shown by WOMAC-physical function subscale (<italic toggle="yes">p</italic> = 0.018), and reduced pain-caused interference with her ability, such as general activity (<italic toggle="yes">p</italic> = 0.022), mood (<italic toggle="yes">p</italic> = 0.033), walking ability (<italic toggle="yes">p</italic> = 0.018), normal work (<italic toggle="yes">p</italic> = 0.022), relations with other people (<italic toggle="yes">p</italic> = 0.047), sleep (<italic toggle="yes">p</italic> = 0.018), and enjoyment of life (<italic toggle="yes">p</italic> = 0.018).</p>
        <fig position="float" id="F1">
          <label>Figure 1</label>
          <caption>
            <p>Effect of TC on pain <bold>(A)</bold>, physical function, and stiffness parameters <bold>(B)</bold>. Data are presented as boxplots and scores from the same subject is connected with a gray line. Statistical significance of differences was determined at an alpha level adjusted for multiple comparisons (i.e., Benjamin-Hochberg adjustment). WOMAC: Pain subscale from 7 (no pain) to 35 (extreme pain); Stiffness subscale from 2 (no stiffness) to 10 (extreme stiffness); Physical function subscale from 17 (no difficulties with activity of daily living) to 85 (extreme difficulties with activity of daily living). Overall WOMAC scale from 26 (best possible score) to 130 (worst possible score) due to knee pain. VAS (visual analog scale) from 0 (no knee pain) to 10 (unbearable pain). BPI (Brief Pain Inventory) from 0 (no pain) to 10 (unbearable pain).</p>
          </caption>
          <graphic xlink:href="fmed-08-775344-g0001" position="float"/>
        </fig>
      </sec>
      <sec>
        <title>Plasma Lipid Panel</title>
        <p><xref rid="T2" ref-type="table">Table 2</xref> lists the effect of 8-week TC on plasma lipids. TC exercise significantly led to lower non-HDL-cholesterol levels (<italic toggle="yes">p</italic> = 0.049). Changes in non-HDL cholesterol and LDL-cholesterol were also large (Cohen's <italic toggle="yes">d</italic> ≥ 0.712), but they were not statistically significant at the adjusted alpha level. Also, TC exercise had no effect on plasma triglycerides, HDL-cholesterol, VLDL-cholesterol, and cholesterol/HDL ratio (all <italic toggle="yes">p</italic> &gt; 0.05).</p>
        <table-wrap position="float" id="T2">
          <label>Table 2</label>
          <caption>
            <p>Effect of group TC on lipid profiles.</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th valign="top" align="left" rowspan="1" colspan="1">
<bold>Parameters</bold>
</th>
                <th valign="top" align="center" rowspan="1" colspan="1">
<bold>Before</bold>
</th>
                <th valign="top" align="center" rowspan="1" colspan="1">
<bold>After</bold>
</th>
                <th valign="top" align="center" rowspan="1" colspan="1">
<italic toggle="yes">
<bold>p</bold>
</italic>
</th>
                <th valign="top" align="center" rowspan="1" colspan="1">
<bold>Cohen's <italic toggle="yes">d</italic></bold>
</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Total cholesterol (mg/dL)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">229.78 ± 64.68</td>
                <td valign="top" align="center" rowspan="1" colspan="1">219.67 ± 60.10</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.201</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.85</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Triglycerides (mg/dL)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">151.44 ± 79.40</td>
                <td valign="top" align="center" rowspan="1" colspan="1">152.22 ± 66.05</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.931</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.03</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">HDL-cholesterol (mg/dL)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">57.22 ± 12.52</td>
                <td valign="top" align="center" rowspan="1" colspan="1">56.00 ± 12.86</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.931</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.22</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Non-HDL cholesterol (mg/dL)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">172.56 ± 63.02</td>
                <td valign="top" align="center" rowspan="1" colspan="1">163.67 ± 58.69</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.049</td>
                <td valign="top" align="center" rowspan="1" colspan="1">1.16</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">LDL-cholesterol (mg/dL)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">141.22 ± 59.40</td>
                <td valign="top" align="center" rowspan="1" colspan="1">132.56 ± 49.68</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.326</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.71</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">VLDL-cholesterol (mg/dL)</td>
                <td valign="top" align="center" rowspan="1" colspan="1">30.44 ± 15.82</td>
                <td valign="top" align="center" rowspan="1" colspan="1">30.78 ± 13.00</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.931</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.06</td>
              </tr>
              <tr>
                <td valign="top" align="left" rowspan="1" colspan="1">Cholesterol/HDL ratio</td>
                <td valign="top" align="center" rowspan="1" colspan="1">4.11 ± 1.28</td>
                <td valign="top" align="center" rowspan="1" colspan="1">4.03 ± 1.26</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.931</td>
                <td valign="top" align="center" rowspan="1" colspan="1">0.26</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <p><italic toggle="yes">Mean ± standard deviation</italic>.</p>
            <p><italic toggle="yes">Cohen's d, effect size indicating the standardized difference in means before and after; HDL, high-density lipoprotein; LDL, low-density lipoprotein; VLDL, very low-density lipoprotein</italic>.</p>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec>
        <title>Plasma Metabolite Levels</title>
        <p>Here, we leveraged an untargeted metabolomics approach to investigate TC effect on 336 identified plasma metabolites. These metabolites comprised several chemical classes, including acylcarnitines, diglycerides, triglycerides, LPC, PC, sphingomyelins, ceramides, and cholesteryl esters. Among all metabolites, 295 metabolites were detected in at least half of the analyzed samples, which were further used in the analysis. Principal component analysis (PCA) of the plasma metabolome profiles revealed a slight clustering of the metabolome profiles before vs. after intervention (<xref rid="F2" ref-type="fig">Figure 2</xref>). Moreover, we observed a shift of the metabolome profiles along the PC1 axis, which explained 28.6% of the variance, which was indicative of changes in the concentration of the metabolites caused by the intervention.</p>
        <fig position="float" id="F2">
          <label>Figure 2</label>
          <caption>
            <p>A principal component analysis (PCA) plot of the plasma metabolites concentration in the subjects (<italic toggle="yes">n</italic> = 10) before and after TC intervention. Samples are colored based on the time-point (before or after intervention) and samples from the same subject are connected by a black line.</p>
          </caption>
          <graphic xlink:href="fmed-08-775344-g0002" position="float"/>
        </fig>
        <p>To identify the individual metabolites of which their concentration was altered by the intervention, we used the Wilcoxon signed-rank test. The change in the concentration of 36 metabolites was statistically significant (<italic toggle="yes">p</italic> &lt; 0.05). We identified 11 and 25 metabolites that decreased and increased after intervention, respectively. Interestingly, the metabolites decreasing after intervention belonged to the chemical classes of biogenic amines and amino acids (<xref rid="F3" ref-type="fig">Figure 3</xref>). The eight biogenic amines included serotonin (<italic toggle="yes">p</italic> = 0.031), <italic toggle="yes">cis</italic>-4-hydroxyproline (c4-OH-Pro) (<italic toggle="yes">p</italic> = 0.040), spermidine (<italic toggle="yes">p</italic> = 0.040), putrescine (<italic toggle="yes">p</italic> = 0.035), sarcosine (<italic toggle="yes">p</italic> = 0.035), symmetric dimethylarginine (SDMA) (<italic toggle="yes">p</italic> = 0.023), asymmetric dimethylarginine (ADMA) (<italic toggle="yes">p</italic> = 0.031), and kynurenine (<italic toggle="yes">p</italic> = 0.040). The three amino acids included methionine (<italic toggle="yes">p</italic> = 0.028) (<xref rid="B71" ref-type="bibr">71</xref>), alanine (<italic toggle="yes">p</italic> = 0.030), and lysine (<italic toggle="yes">p</italic> = 0.031) (<xref rid="F3" ref-type="fig">Figure 3</xref>). In contrast, all metabolites that increased after intervention were lipids; 17 of which were LPC [namely, LPC(14:0), <italic toggle="yes">p</italic> = 0.035; LPC(15:0), <italic toggle="yes">p</italic> = 0.028; LPC(16:0), <italic toggle="yes">p</italic> = 0.030; LPC(16:1), <italic toggle="yes">p</italic> = 0.031; LPC(17:0), <italic toggle="yes">p</italic> = 0.030; LPC(17:1), <italic toggle="yes">p</italic> = 0.031; LPC(18:0), <italic toggle="yes">p</italic> = 0.028; LPC(18:1), <italic toggle="yes">p</italic> = 0.038; LPC(18:2), <italic toggle="yes">p</italic> = 0.040; LPC(20:1), <italic toggle="yes">p</italic> = 0.023; LPC(20:3), <italic toggle="yes">p</italic> = 0.023; LPC(20:4), <italic toggle="yes">p</italic> = 0.030; LPC(22:5), <italic toggle="yes">p</italic> = 0.031; LPC(22:6), <italic toggle="yes">p</italic> = 0.023; LPC-O(16:1), <italic toggle="yes">p</italic> = 0.040; LPC-O(18:1), <italic toggle="yes">p</italic> = 0.031; LPC-O(18:2), <italic toggle="yes">p</italic> = 0.023], five PC [namely, PC(36:5), <italic toggle="yes">p</italic> = 0.040; PC(38:6), <italic toggle="yes">p</italic> = 0.031; PC(40:9), <italic toggle="yes">p</italic> = 0.031; PC(42:10), <italic toggle="yes">p</italic> = 0.031; PC(43:6), <italic toggle="yes">p</italic> = 0.035)], one diglyceride (34:1) (<italic toggle="yes">p</italic> = 0.023), one cholesteryl ester (18:1) (<italic toggle="yes">p</italic> = 0.044), and an acylcarnitine (18:2) (<italic toggle="yes">p</italic> = 0.040) (<xref rid="F4" ref-type="fig">Figure 4</xref>).</p>
        <fig position="float" id="F3">
          <label>Figure 3</label>
          <caption>
            <p>Boxplot shows the concentration of amino acids metabolites before and after TC intervention. Paired samples are linked by a line for each subject. All shown metabolites were significantly decreased after intervention (adjusted <italic toggle="yes">p</italic> &lt; 0.05). ADMA, asymmetric dimethylarginine; Ala, alanine; c4-OH-Pro, cis-4-hydroxyproline; Lys, lysine; Met, methionine; SDMA, symmetric dimethylarginine.</p>
          </caption>
          <graphic xlink:href="fmed-08-775344-g0003" position="float"/>
        </fig>
        <fig position="float" id="F4">
          <label>Figure 4</label>
          <caption>
            <p>Boxplot shows the concentration of lipids metabolites before and after TC intervention. Paired samples are linked by a line for each subject. All shown metabolites were significantly increased after intervention (<italic toggle="yes">p</italic> &lt; 0.05).</p>
          </caption>
          <graphic xlink:href="fmed-08-775344-g0004" position="float"/>
        </fig>
      </sec>
      <sec>
        <title>Brain Functional and Structural Connectivity</title>
        <p>After 8 weeks of TC intervention, clusters in mPFC showed increased rs-fMRI connectivity with the left amygdala as shown in orange-yellow color (<xref rid="F5" ref-type="fig">Figure 5A</xref>) and the mPFC clusters showed increased rs-fMRI connectivity with the right amygdala in blue color (<xref rid="F5" ref-type="fig">Figure 5B</xref>) in the subgroup (<italic toggle="yes">n</italic> = 7) of subjects with knee OA. However, the pre-post difference was not significant (left amygdala with <italic toggle="yes">d</italic> = 0.988, <italic toggle="yes">p</italic> = 0.355, right amygdala with <italic toggle="yes">d</italic> = 0.600, <italic toggle="yes">p</italic> = 0.282). Similarly, DTI analyses revealed a pre-post increase in structural connectivity between bilateral mPFC and each of left amygdala (<italic toggle="yes">p</italic> = 0.156, <italic toggle="yes">d</italic> = 0.720) and right amygdala (<italic toggle="yes">p</italic> = 0.219, <italic toggle="yes">d</italic> = 0.528).</p>
        <fig position="float" id="F5">
          <label>Figure 5</label>
          <caption>
            <p>Transverse sections of the brain depicting regions within the mPFC that showed a post- vs. pre-TC intervention increase in rs-fMRI connectivity in with the <bold>(A)</bold> left amygdala (orange-yellow) and <bold>(B)</bold> right amygdala (<xref rid="B64" ref-type="bibr">64</xref>) after 8-week TC intervention. The functional maps have been registered on the mean of T1-weighted structural images of all participants. An increase in rs-fMRI connectivity was observed between bilateral mPFC and the left amygdala [<italic toggle="yes">n</italic> = 7, <italic toggle="yes">p</italic> = 0.355, <bold>(A)</bold>] and right amygdala [<italic toggle="yes">n</italic> = 7, <italic toggle="yes">p</italic> = 0.282; <bold>(B)</bold>] seed regions with 8 weeks of TC intervention. The images represent within-subject pre-post comparisons. After correcting to maintain family-wise error rate at 0.05, none of the observed changes remained statistically significant.</p>
          </caption>
          <graphic xlink:href="fmed-08-775344-g0005" position="float"/>
        </fig>
        <p><xref rid="F6" ref-type="fig">Figure 6</xref> shows the correlation between post- vs. pre-TC intervention changes in fMRI connectively and physical function parameters. We found that there were moderate-strong non-linear correlations between pain and physical function parameters and the behavioral parameters, although these correlations were not significant, except for R/amygdala-mPFC DTI connectivity and stiffness with a negative correlation trend (unadjusted <italic toggle="yes">p</italic> = 0.063). For instance, there was a positive non-linear correlation between post- vs. pre-Tai Chi intervention change in physical function and L/amygdala-mPFC rs-fMRI connectivity (ρ = 0.577, unadjusted <italic toggle="yes">p</italic> = 0.231), suggesting that improvements in physical function may be associated with increased rs-fMRI connectivity (i.e., reversal of the pain-induced functional disconnect) between the L/amygdala and mPFC. Similarly, there was a negative non-linear correlation between post- vs. pre-TC intervention change in stiffness and R/amygdala-mPFC DTI connectivity (ρ = −0.727, unadjusted <italic toggle="yes">p</italic> = 0.063), suggesting that decreased stiffness with exposure to TC intervention may be associated with increased structural white matter connectivity between the R/amygdala and mPFC.</p>
        <fig position="float" id="F6">
          <label>Figure 6</label>
          <caption>
            <p>Cross correlations between post- vs. pre-TC intervention changes in amygdala-mPFC rs-fMRI / DTI connectivity and the corresponding changes in pain/physical function. The left lower half of the figure depicts univariate scatter plots with Loess regression lines. The diagonal of the figure depicts probability distribution functions of each variable. The right upper half of the figure presents the Spearman's rho (ρ) of each univariate correlation, the corresponding unadjusted <italic toggle="yes">p</italic>-value (<italic toggle="yes">p</italic>) and the <italic toggle="yes">p</italic>-value adjusted for using the Benjamini-Hochberg procedure (<italic toggle="yes">p</italic>'). LAF, L/amygdala-mPFC functional connectivity; RAF, R/amygdala-mPFC functional connectivity; LAD, L/amygdala-mPFC DTI connectivity; RAD, R/amygdala-mPFC DTI connectivity; Physical, physical function.</p>
          </caption>
          <graphic xlink:href="fmed-08-775344-g0006" position="float"/>
        </fig>
      </sec>
    </sec>
    <sec sec-type="discussion" id="s4">
      <title>Discussion</title>
      <p>To our knowledge, this pilot study is the first to examine the effects of TC group intervention on both resting state functional and structural connectivity between the amygdala and mPFC. These networks involved in pain processing have been studied in humans with pain status (<xref rid="B18" ref-type="bibr">18</xref>, <xref rid="B57" ref-type="bibr">57</xref>, <xref rid="B69" ref-type="bibr">69</xref>). Connectivity between mPFC and amygdala has been identified as a predictor for chronic pain and pain vulnerability. Functional connectivity of the amygdala and mPFC has been consistently shown to increase in chronic pain, such as OA pain, indicating the importance of functional connectivity in human pain regulation (<xref rid="B65" ref-type="bibr">65</xref>). Resting state functional and structural (i.e., white matter) connectivity of the amygdala with mPFC has also received great attention as an important neurobiomarker of chronic pain (<xref rid="B72" ref-type="bibr">72</xref>) and transition to chronic pain from sub-acute states of pain (<xref rid="B18" ref-type="bibr">18</xref>). Thus, there is sufficient empirical support to suggest that mPFC-amygdala connectivity decreases in chronic pain states, including knee OA pain. Given that chronic pain conditions such as knee OA have been linked to decreased functional connectivity between the amygdala and mPFC, the moderate effect sizes observed in rs-fMRI or DTI connectivity in pre- and post-TC intervention we report in this pilot study reflect an increase in amygdala-mPFC connectivity after 8 weeks of TC intervention. This observed increase in structural connectivity, while not statistically significant, indicates the possibility of reversal of chronic pain associated-brain changes following TC intervention in subjects with knee OA pain. Our self-reported pain reduction results of WOMAC and BPI in OA subjects provide evidence in supporting the fMRI findings of subjects after 8 weeks of TC intervention.</p>
      <p>Excessive oxidative stress and systemic low-grade inflammation are found to be upregulated in OA (<xref rid="B73" ref-type="bibr">73</xref>). In the integration of the metabolomics data along with brain functional/structural connectivity and clinical data from the present study may yield additional insights on TC and pain. To our knowledge, this study is the first to examine the effect of TC intervention on plasma amino acid and lipid metabolites along with brain functional and structural connectivity in knee OA patients.</p>
      <p>Amino acids (AA), polyamines, and lipid biochemicals play a significant role in maintaining the balance between ROS and antioxidant systems. Chen et al. reported that in OA patients, compared to non-OA controls, the levels of 10 metabolites [alanine, arginine, creatine, c4-OH-Pro, isoleucine, leucine, lysine, tryptophan, tyrosine, and valine] were higher, whereas 12 AA metabolites [acetyl-carnitine, γ-aminobutyric acid (GABA), asparagine, citrulline, creatinine, dimethylglycine, glutamine, phenylalanine, proline, serine, and taurine] were lower (<xref rid="B74" ref-type="bibr">74</xref>). Among the metabolic pathways of the changed AA, the most significant involved Ala, c4-OH-Pro, arginine, aspartate, and glutamate (<xref rid="B74" ref-type="bibr">74</xref>). Senol et al. also reported compared to non-OA subjects, OA subjects had higher levels of alanine, isoleucine, leucine, valine, and lower levels of L-Ornithine, associated with energy metabolism (<xref rid="B75" ref-type="bibr">75</xref>). Alanine is connected with sclerosis in subchondral bone and may indicate greater energy consumption in OA (<xref rid="B76" ref-type="bibr">76</xref>). c4-OH-Pro is important to skeletal health, and is also considered as a marker of bone turnover and resorption in bone remodeling (<xref rid="B77" ref-type="bibr">77</xref>). In this study, the findings that TC intervention decreased plasma alanine, and c4-OH-Pro provides evidence on how TC could benefit OA patients in supporting anabolic metabolism and energy production in the no-OA control or recovery of OA.</p>
      <p>Increased serum arginine level in OA has been associated with the nitric oxide synthase (<xref rid="B78" ref-type="bibr">78</xref>) function. NOS releases nitric oxide from arginine and has an endogenous metabolic inhibitor ADMA (<xref rid="B26" ref-type="bibr">26</xref>). Moreover, the spermine-spermidine system protects against oxidative stress by scavenging free radicals and regulating other antioxidant mechanisms (<xref rid="B79" ref-type="bibr">79</xref>–<xref rid="B81" ref-type="bibr">81</xref>). The increased circulating spermidine and lower spermine to spermidine ratio have been linked to excessive oxidative stress in OA patients. Such increased spermidine in OA patients might result by the lower activity of spermine synthase, an enzyme that converts spermidine to spermine. The accumulation of spermidine impairs lysosome function and leads to increase oxidative stress (<xref rid="B80" ref-type="bibr">80</xref>). Tootsi et al. reported that (1) an elevated level of ADMA in OA patients that suppresses NOS activity, results in decline utilization of arginine and (2) significantly increased levels of arginine, asparagine, leucine, serine, phenylalanine, and spermidine, whereas the ratio of spermine to spermidine was decreased in the OA patients, reflecting an excess of oxidative stress (<xref rid="B26" ref-type="bibr">26</xref>). In the present study, the findings that TC intervention significantly reduced arginine metabolites (i.e., SDMA and ADMA) and spermidine provide evidence of TC's anti-oxidative stress action. Our finding corroborates with the previous studies showing TC exercise reduced oxidative stress, as shown by reduced urinary 8-hydroxy-2'-deoxyguanosine (oxidative stress biomarker) (<xref rid="B81" ref-type="bibr">81</xref>) and serum lipoperoxides (<xref rid="B82" ref-type="bibr">82</xref>–<xref rid="B85" ref-type="bibr">85</xref>).</p>
      <p>Serotonin is mostly known for its function as a neurotransmitter and it has been found to be involved in pain and inflammation, showing pro- and anti-nociceptive effects of serotonin through the distinct receptor (<xref rid="B86" ref-type="bibr">86</xref>). Seidel et al. reported serotonin mediates PGE<sub>2</sub> overexpression through 5-HT2A and 5-HT3 receptor subtypes in serum-free tissue culture of macrophage-like synovial cells, suggesting the involvement of elevated serotonin in progression of OA (<xref rid="B87" ref-type="bibr">87</xref>). Ji et al. also reported that knockdown of 5-HT2C in the amygdala has beneficial effects on chronic pain, which is in line with the data reported here that TC exerts beneficial effects through reduction of 5-HT (<xref rid="B88" ref-type="bibr">88</xref>).</p>
      <p>The kynurenine pathway of tryptophan metabolism has been implicated in the pathogenesis of inflammation, including OA (<xref rid="B30" ref-type="bibr">30</xref>, <xref rid="B88" ref-type="bibr">88</xref>, <xref rid="B89" ref-type="bibr">89</xref>). Lögters et al. demonstrated that (i) synovial kynurenine values and ratio of kynurenine/tryptophan in septic arthritis patients were significantly increased compared to patients with non-infectious inflammatory arthropathy or OA (<xref rid="B30" ref-type="bibr">30</xref>), and there is a significant positive correlation between kynurenine values and synovial interleukin-1β and interleukin-6 in synovial fluid, indicating that the activation of kynurenic pathway is a consequence of inflammation (<xref rid="B89" ref-type="bibr">89</xref>). Intriguingly, Lögters' findings would provide an explanation for TC's anti-inflammation on OA as shown by significant reduction in plasma kynurenine of OA subjects.</p>
      <p>A number of studies have identified altered status of glycolysis and glucose metabolism glycolytic proteins in OA (<xref rid="B90" ref-type="bibr">90</xref>, <xref rid="B91" ref-type="bibr">91</xref>). For example, Anderson et al. reported that OA patients had significantly higher levels of substrates for glycolysis and the TCA cycle, including sarcosine, glucose, mannose, pyruvate and citrate. In addition, many amino acids, which feed into glycolysis and the TCA cycle, were higher in OA, including alanine, tyrosine, glutamine, proline, histidine, asparagine, and taurine (<xref rid="B92" ref-type="bibr">92</xref>). In the present study, we reported TC intervention resulted in a reduction in plasma putrescine, sarcosine, and alanine of OA subjects, suggesting TC may play an important role in chondrocyte protection of OA <italic toggle="yes">via</italic> improving glucose metabolism. Future study is warranted to confirm our pilot findings.</p>
      <p>While our study focused on brain circuits to explain beneficial effects of TC, the various plasma metabolites implicated in TC here could also act on peripheral targets such as transient receptor potential vanilloid 1 (TRPV1), which is expressed in nociceptors and has been linked to OA and OA pain in preclinical and clinical studies (<xref rid="B90" ref-type="bibr">90</xref>, <xref rid="B91" ref-type="bibr">91</xref>). TRPV1 was discovered as a thermosensor and subsequently a nociceptor by Nobel Laureate Dr. David Julius (<xref rid="B93" ref-type="bibr">93</xref>). TRPV1 signaling can be activated or facilitated by a number of endogenous factors and intracellular signaling mechanisms, including extracellular protons at levels found in tissue acidosis associated with arthritis and other conditions (<xref rid="B94" ref-type="bibr">94</xref>), cannabinoid anandamide (<xref rid="B95" ref-type="bibr">95</xref>), bioactive lipids such as LPC (<xref rid="B96" ref-type="bibr">96</xref>), and PLA2 (<xref rid="B97" ref-type="bibr">97</xref>); these may be modulated in TC because we found changes in amino acids, lipids, PC to LPC levels and evidence for conversion (<xref rid="B98" ref-type="bibr">98</xref>).</p>
      <p>OA patients have impaired lipid metabolism, which might be the result of increased energy requirement and decreased supply of lipids (<xref rid="B99" ref-type="bibr">99</xref>). Severe OA patients may have higher energy requirements (hypertrophic chondrocytes, production of inflammatory mediators); at the same time, the energy supply from lipid β-oxidation may be impaired (inadequate enzyme functioning) (<xref rid="B99" ref-type="bibr">99</xref>). In a case-control study, Tootsi et al. reported medium- and long-chain acylcarnitines were significantly lower in the OA subjects than the non-OA subjects, and the acylcarnitines levels were negatively associated with OA severity as well as with arterial stiffness in end-stage OA patients (<xref rid="B99" ref-type="bibr">99</xref>). Thus, acylcarnities might play an important role in the association between OA and cardiovascular disease (<xref rid="B99" ref-type="bibr">99</xref>); however, the investigators used a kit for the acylcarnitine measurements. The lower level of acylcarnitines might be caused by carnitine deficiency or by increased energy consumption in OA. One of the causes of increased energy expenditure is inflammation. In the present study, TC intervention resulted in higher plasma acylcarnitines levels determined by UHPLC, suggesting TC's potential in reducing inflammation which was reported previously (<xref rid="B100" ref-type="bibr">100</xref>). In contrast, others observed that 8-week TC intervention reduced non-HDL cholesterol of knee OA subjects agrees with published meta-analysis work (<xref rid="B101" ref-type="bibr">101</xref>). Different from published work with subjects at high risk of cardiovascular disease, our study is the first study in postmenopausal women with knee OA pain. The higher plasma acylcarnitines after TC intervention would show TC's benefit on OA patients in the aspect of cardiovascular health.</p>
      <p>In animal OA models, Pousinis et al. suggested potential OA biomarkers to include those associated with cholesterol biosynthesis, sphingolipid metabolism, and arachidonic acid metabolism, and linoleic acid, alpha-linolenic acid, and glycerophospholipid (<xref rid="B102" ref-type="bibr">102</xref>). Overall cholesteryl ester (CE) (18:2), CE (20:4), and CE (22:6) levels were positively correlated with pain behavior (<xref rid="B102" ref-type="bibr">102</xref>). In our study, we found CE (18:1) and diglyceride (<xref rid="B103" ref-type="bibr">103</xref>) (34:1) elevated in OA subjects after 8 weeks of TC intervention. Interestingly, we also found that TC exercise led to higher levels of diglyceride and cholesterol ester, suggesting TC exercise could increase catabolism of lipids.</p>
      <p>Metabolites of PC and LPC are shown to associate with the progression of OA (<xref rid="B28" ref-type="bibr">28</xref>, <xref rid="B99" ref-type="bibr">99</xref>, <xref rid="B100" ref-type="bibr">100</xref>). Tootsi et al. reported compared to non-OA group, OA group had significantly lower serum LPC acyl C14:0, PC diacyl C30:0, PC diacyl C32:2, PC diacyl C32:3, PC diacyl C34:3, PC diacyl C34:4, PC acyl-alkyl C30:0, PC acyl-alkyl C34:2 and PC acyl-alkyl C34:3, and higher levels of LPC acyl C20:4, PC diacyl C38:6, PC diacyl C40:6, and SM C20:2, suggesting the conversion pathway of PC to LPC being overactivated in OA patients with greater level of systemic inflammation (<xref rid="B26" ref-type="bibr">26</xref>). In the present study, we identified 25 lipid metabolites that were elevated after TC intervention. Among these 25 elevated lipid metabolites, 68 and 20% were classified as LPC and PC, respectively, with the remaining metabolites annotated as acylcarnitines (AC 18:2), diglycerides (<xref rid="B103" ref-type="bibr">103</xref>), and cholesteryl esters. The finding that elevation of plasma LPC and PC levels in knee of OA subjects after 8 weeks of TC intervention suggests TC's anti-inflammatory action.</p>
      <p>In this pilot study, we did find connectivity improvements between the amygdala and mPFC with TC intervention after appropriate thresholds, but they did not reach a level of statistical significance. The lack of significance could be due to the following reasons/limitations: (i) a pre-post setting with a small sample size for fMRI assessment which may be a high likelihood of the correlation being driven by extreme outliers (<xref rid="B28" ref-type="bibr">28</xref>), (ii) lack of a comparison group without TC intervention which may result in the observed effects could simply be due to regression toward the mean, and (iii) due to the limited sample size, thresholding of functional images was performed using an ordinary least squares approach, which is known to inflate type I error rates (<xref rid="B104" ref-type="bibr">104</xref>). Thus, caution is advised in interpreting the pre-post comparisons a well as the magnitude of correlations in this preliminary, exploratory study. A future randomized control study to include a comparison group without TC intervention with adequate power is warranted to confirm the observed effects of the present study, with a focus on how TC, a mind-body exercise, might strengthen functional and structural connectivity between the mPFC and the amygdala.</p>
    </sec>
    <sec sec-type="conclusions" id="s5">
      <title>Conclusion</title>
      <p>This study revealed moderate to large effect sizes, suggesting an important role for cortico-amygdala interactions due to TC intervention on pain and physical function in postmenopausal women with knee OA. TC intervention increases lysophosphatidylcholines and decreases some essential amino acids in plasma of postmenopausal women with knee OA.</p>
    </sec>
    <sec sec-type="data-availability" id="s6">
      <title>Data Availability Statement</title>
      <p>The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.</p>
    </sec>
    <sec id="s7">
      <title>Ethics Statement</title>
      <p>The studies involving human participants were reviewed and approved by Institutional Review Board at Texas Tech University Health Sciences Center. The patients/participants provided their written informed consent to participate in this study.</p>
    </sec>
    <sec id="s8">
      <title>Author Contributions</title>
      <p>C-LS, BW, CK, M-CC, H-YL, J-MB, JL, MZ, TW, and VN: conceptualization and methodology. CK, M-CC, MZ-M, ME, H-YL, J-MB, AK, JL, and RW: data collection and analysis. C-LS, BW, CK, MZ-M, ME, and VN: writing—original draft preparation. C-LS, BW, CK, M-CC, MZ-M, ME, H-YL, J-MB, JL, TW, and VN: writing—review and editing. C-LS and VN: supervision, project administration, and funding acquisition. All authors have read and agreed to the published version of the manuscript.</p>
    </sec>
    <sec sec-type="funding-information" id="s9">
      <title>Funding</title>
      <p>This study was supported by Center of Excellence for Translational Neuroscience and Therapeutics, Texas Tech University Health Sciences Center, Lubbock, TX (grant no: PN-CTNT 2018-12 LSVNBAW).</p>
    </sec>
    <sec sec-type="COI-statement" id="conf1">
      <title>Conflict of Interest</title>
      <p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
    </sec>
    <sec sec-type="disclaimer" id="s10">
      <title>Publisher's Note</title>
      <p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
    </sec>
  </body>
  <back>
    <ack>
      <p>We thank TTUHSC Clinical Research Institute staff for their support in data collection and project coordination. We also thank Jeff Roark for offering Tai Chi sessions, Michael O'Boyle for interpreting fMRI data, and Jacob Lovett for editing work.</p>
    </ack>
    <ref-list>
      <title>References</title>
      <ref id="B1">
        <label>1.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murphy</surname><given-names>L</given-names></name><name><surname>Schwartz</surname><given-names>TA</given-names></name><name><surname>Helmick</surname><given-names>CG</given-names></name><name><surname>Renner</surname><given-names>JB</given-names></name><name><surname>Tudor</surname><given-names>G</given-names></name><name><surname>Koch</surname><given-names>G</given-names></name><etal/></person-group>. <article-title>Lifetime risk of symptomatic knee osteoarthritis</article-title>. <source>Arthritis Rheum.</source> (<year>2008</year>) <volume>59</volume>:<fpage>1207</fpage>–<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1002/art.24021</pub-id><pub-id pub-id-type="pmid">18759314</pub-id></mixed-citation>
      </ref>
      <ref id="B2">
        <label>2.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murphy</surname><given-names>SL</given-names></name><name><surname>Schepens Niemiec</surname><given-names>S</given-names></name><name><surname>Lyden</surname><given-names>AK</given-names></name><name><surname>Kratz</surname><given-names>AL</given-names></name></person-group>. <article-title>Pain, fatigue, and physical activity in osteoarthritis: the moderating effects of pain- and fatigue-related activity interference</article-title>. <source>Arch Phys Med Rehabil.</source> (<year>2016</year>) <volume>97</volume>(<issue>9Suppl.</issue>):<fpage>S201</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.apmr.2015.05.025</pub-id><pub-id pub-id-type="pmid">27207435</pub-id></mixed-citation>
      </ref>
      <ref id="B3">
        <label>3.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhatia</surname><given-names>D</given-names></name><name><surname>Bejarano</surname><given-names>T</given-names></name><name><surname>Novo</surname><given-names>M</given-names></name></person-group>. <article-title>Current interventions in the management of knee osteoarthritis</article-title>. <source>J Pharm Bioallied Sci.</source> (<year>2013</year>) <volume>5</volume>:<fpage>30</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.4103/0975-7406.106561</pub-id><pub-id pub-id-type="pmid">23559821</pub-id></mixed-citation>
      </ref>
      <ref id="B4">
        <label>4.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gambardella</surname><given-names>S</given-names></name><name><surname>Limanaqi</surname><given-names>F</given-names></name><name><surname>Ferese</surname><given-names>R</given-names></name><name><surname>Biagioni</surname><given-names>F</given-names></name><name><surname>Campopiano</surname><given-names>R</given-names></name><name><surname>Centonze</surname><given-names>D</given-names></name><etal/></person-group>. <article-title>ccf-mtDNA as a potential link between the brain and immune system in neuro-immunological disorders</article-title>. <source>Front Immunol.</source> (<year>2019</year>) <volume>10</volume>:<fpage>1064</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2019.01064</pub-id><pub-id pub-id-type="pmid">31143191</pub-id></mixed-citation>
      </ref>
      <ref id="B5">
        <label>5.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lapane</surname><given-names>KL</given-names></name><name><surname>Yang</surname><given-names>S</given-names></name><name><surname>Jawahar</surname><given-names>R</given-names></name><name><surname>McAlindon</surname><given-names>T</given-names></name><name><surname>Eaton</surname><given-names>CB</given-names></name></person-group>. <article-title>CAM use among overweight and obese persons with radiographic knee osteoarthritis</article-title>. <source>BMC Complement Altern Med.</source> (<year>2013</year>) <volume>13</volume>:<fpage>241</fpage>. <pub-id pub-id-type="doi">10.1186/1472-6882-13-241</pub-id><pub-id pub-id-type="pmid">24073985</pub-id></mixed-citation>
      </ref>
      <ref id="B6">
        <label>6.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brismee</surname><given-names>JM</given-names></name><name><surname>Paige</surname><given-names>RL</given-names></name><name><surname>Chyu</surname><given-names>MC</given-names></name><name><surname>Boatright</surname><given-names>JD</given-names></name><name><surname>Hagar</surname><given-names>JM</given-names></name><name><surname>McCaleb</surname><given-names>JA</given-names></name><etal/></person-group>. <article-title>Group and home-based tai chi in elderly subjects with knee osteoarthritis: a randomized controlled trial</article-title>. <source>Clin Rehabil.</source> (<year>2007</year>) <volume>21</volume>:<fpage>99</fpage>–<lpage>111</lpage>. <pub-id pub-id-type="doi">10.1177/0269215506070505</pub-id><pub-id pub-id-type="pmid">17264104</pub-id></mixed-citation>
      </ref>
      <ref id="B7">
        <label>7.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fransen</surname><given-names>M</given-names></name><name><surname>Nairn</surname><given-names>L</given-names></name><name><surname>Winstanley</surname><given-names>J</given-names></name><name><surname>Lam</surname><given-names>P</given-names></name><name><surname>Edmonds</surname><given-names>J</given-names></name></person-group>. <article-title>Physical activity for osteoarthritis management: a randomized controlled clinical trial evaluating hydrotherapy or Tai Chi classes</article-title>. <source>Arthritis Rheum.</source> (<year>2007</year>) <volume>57</volume>:<fpage>407</fpage>–<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1002/art.22621</pub-id><pub-id pub-id-type="pmid">17443749</pub-id></mixed-citation>
      </ref>
      <ref id="B8">
        <label>8.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>HJ</given-names></name><name><surname>Park</surname><given-names>HJ</given-names></name><name><surname>Chae</surname><given-names>Y</given-names></name><name><surname>Kim</surname><given-names>SY</given-names></name><name><surname>Kim</surname><given-names>SN</given-names></name><name><surname>Kim</surname><given-names>ST</given-names></name><etal/></person-group>. <article-title>Tai Chi Qigong for the quality of life of patients with knee osteoarthritis: a pilot, randomized, waiting list controlled trial</article-title>. <source>Clin Rehabil.</source> (<year>2009</year>) <volume>23</volume>:<fpage>504</fpage>–<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1177/0269215508101746</pub-id><pub-id pub-id-type="pmid">19389743</pub-id></mixed-citation>
      </ref>
      <ref id="B9">
        <label>9.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>R</given-names></name><name><surname>Lee</surname><given-names>EO</given-names></name><name><surname>Lam</surname><given-names>P</given-names></name><name><surname>Bae</surname><given-names>SC</given-names></name></person-group>. <article-title>Effects of tai chi exercise on pain, balance, muscle strength, and perceived difficulties in physical functioning in older women with osteoarthritis: a randomized clinical trial</article-title>. <source>J Rheumatol.</source> (<year>2003</year>) <volume>30</volume>:<fpage>2039</fpage>–<lpage>44</lpage>.<pub-id pub-id-type="pmid">12966613</pub-id></mixed-citation>
      </ref>
      <ref id="B10">
        <label>10.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Schmid</surname><given-names>CH</given-names></name><name><surname>Iversen</surname><given-names>MD</given-names></name><name><surname>Harvey</surname><given-names>WF</given-names></name><name><surname>Fielding</surname><given-names>RA</given-names></name><name><surname>Driban</surname><given-names>JB</given-names></name><etal/></person-group>. <article-title>Comparative effectiveness of tai chi versus physical therapy for knee osteoarthritis: a randomized trial</article-title>. <source>Ann Intern Med.</source> (<year>2016</year>) <volume>165</volume>:<fpage>77</fpage>–<lpage>86</lpage>. <pub-id pub-id-type="doi">10.7326/M15-2143</pub-id><pub-id pub-id-type="pmid">27183035</pub-id></mixed-citation>
      </ref>
      <ref id="B11">
        <label>11.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neugebauer</surname><given-names>V</given-names></name><name><surname>Mazzitelli</surname><given-names>M</given-names></name><name><surname>Cragg</surname><given-names>B</given-names></name><name><surname>Ji</surname><given-names>G</given-names></name><name><surname>Navratilova</surname><given-names>E</given-names></name><name><surname>Porreca</surname><given-names>F</given-names></name></person-group>. <article-title>Amygdala, neuropeptides, and chronic pain-related affective behaviors</article-title>. <source>Neuropharmacology.</source> (<year>2020</year>) <volume>170</volume>:<fpage>108052</fpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2020.108052</pub-id><pub-id pub-id-type="pmid">32188569</pub-id></mixed-citation>
      </ref>
      <ref id="B12">
        <label>12.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>TD</given-names></name><name><surname>Valdivia</surname><given-names>S</given-names></name><name><surname>Khan</surname><given-names>A</given-names></name><name><surname>Ahn</surname><given-names>HS</given-names></name><name><surname>Adke</surname><given-names>AP</given-names></name><name><surname>Martinez Gonzalez</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Dual and opposing functions of the central amygdala in the modulation of pain</article-title>. <source>Cell Rep</source>. (<year>2019</year>) <volume>29</volume>:<fpage>332</fpage>–<lpage>46</lpage> e5. <pub-id pub-id-type="doi">10.1016/j.celrep.2019.09.011</pub-id><pub-id pub-id-type="pmid">31597095</pub-id></mixed-citation>
      </ref>
      <ref id="B13">
        <label>13.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ji</surname><given-names>G</given-names></name><name><surname>Neugebauer</surname><given-names>V</given-names></name></person-group>. <article-title>Pain-related deactivation of medial prefrontal cortical neurons involves mGluR1 and GABA(A) receptors</article-title>. <source>J Neurophysiol.</source> (<year>2011</year>) <volume>106</volume>:<fpage>2642</fpage>–<lpage>52</lpage>. <pub-id pub-id-type="doi">10.1152/jn.00461.2011</pub-id><pub-id pub-id-type="pmid">21880942</pub-id></mixed-citation>
      </ref>
      <ref id="B14">
        <label>14.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baliki</surname><given-names>MN</given-names></name><name><surname>Geha</surname><given-names>PY</given-names></name><name><surname>Jabakhanji</surname><given-names>R</given-names></name><name><surname>Harden</surname><given-names>N</given-names></name><name><surname>Schnitzer</surname><given-names>TJ</given-names></name><name><surname>Apkarian</surname><given-names>AV</given-names></name><etal/></person-group>. <article-title>Preliminary fMRI study of analgesic treatment in chronic back pain and knee osteoarthritis</article-title>. <source>Mol Pain.</source> (<year>2008</year>) <volume>4</volume>:<fpage>47</fpage>. <pub-id pub-id-type="doi">10.1186/1744-8069-4-47</pub-id><pub-id pub-id-type="pmid">18950528</pub-id></mixed-citation>
      </ref>
      <ref id="B15">
        <label>15.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pujol</surname><given-names>J</given-names></name><name><surname>Martinez-Vilavella</surname><given-names>G</given-names></name><name><surname>Llorente-Onaindia</surname><given-names>J</given-names></name><name><surname>Harrison</surname><given-names>BJ</given-names></name><name><surname>Lopez-Sola</surname><given-names>M</given-names></name><name><surname>Lopez-Ruiz</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Brain imaging of pain sensitization in patients with knee osteoarthritis</article-title>. <source>Pain.</source> (<year>2017</year>) <volume>158</volume>:<fpage>1831</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1097/j.pain.0000000000000985</pub-id><pub-id pub-id-type="pmid">28683024</pub-id></mixed-citation>
      </ref>
      <ref id="B16">
        <label>16.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Hu</surname><given-names>K</given-names></name><name><surname>Tu</surname><given-names>Y</given-names></name><name><surname>Lin</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Modulatory effects of different exercise modalities on the functional connectivity of the periaqueductal grey and ventral tegmental area in patients with knee osteoarthritis: a randomised multimodal magnetic resonance imaging study</article-title>. <source>Br J Anaesth.</source> (<year>2019</year>) <volume>123</volume>:<fpage>506</fpage>–<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1016/j.bja.2019.06.017</pub-id><pub-id pub-id-type="pmid">31395306</pub-id></mixed-citation>
      </ref>
      <ref id="B17">
        <label>17.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cottam</surname><given-names>WJ</given-names></name><name><surname>Iwabuchi</surname><given-names>SJ</given-names></name><name><surname>Drabek</surname><given-names>MM</given-names></name><name><surname>Reckziegel</surname><given-names>D</given-names></name><name><surname>Auer</surname><given-names>DP</given-names></name></person-group>. <article-title>Altered connectivity of the right anterior insula drives the pain connectome changes in chronic knee osteoarthritis</article-title>. <source>Pain.</source> (<year>2018</year>) <volume>159</volume>:<fpage>929</fpage>–<lpage>38</lpage>. <pub-id pub-id-type="doi">10.1097/j.pain.0000000000001209</pub-id><pub-id pub-id-type="pmid">29557928</pub-id></mixed-citation>
      </ref>
      <ref id="B18">
        <label>18.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vachon-Presseau</surname><given-names>E</given-names></name><name><surname>Tetreault</surname><given-names>P</given-names></name><name><surname>Petre</surname><given-names>B</given-names></name><name><surname>Huang</surname><given-names>L</given-names></name><name><surname>Berger</surname><given-names>SE</given-names></name><name><surname>Torbey</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Corticolimbic anatomical characteristics predetermine risk for chronic pain</article-title>. <source>Brain</source>. (<year>2016</year>) <volume>139</volume>:<fpage>1958</fpage>–<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1093/brain/aww100</pub-id><pub-id pub-id-type="pmid">27190016</pub-id></mixed-citation>
      </ref>
      <ref id="B19">
        <label>19.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vachon-Presseau</surname><given-names>E</given-names></name><name><surname>Centeno</surname><given-names>MV</given-names></name><name><surname>Ren</surname><given-names>W</given-names></name><name><surname>Berger</surname><given-names>SE</given-names></name><name><surname>Tetreault</surname><given-names>P</given-names></name><name><surname>Ghantous</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>The emotional brain as a predictor and amplifier of chronic pain</article-title>. <source>J Dent Res.</source> (<year>2016</year>) <volume>95</volume>:<fpage>605</fpage>–<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1177/0022034516638027</pub-id><pub-id pub-id-type="pmid">26965423</pub-id></mixed-citation>
      </ref>
      <ref id="B20">
        <label>20.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kiritoshi</surname><given-names>T</given-names></name><name><surname>Neugebauer</surname><given-names>V</given-names></name></person-group>. <article-title>Pathway-specific alterations of cortico-amygdala transmission in an arthritis pain model</article-title>. <source>ACS Chem Neurosci.</source> (<year>2018</year>) <volume>9</volume>:<fpage>2252</fpage>–<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1021/acschemneuro.8b00022</pub-id><pub-id pub-id-type="pmid">29630339</pub-id></mixed-citation>
      </ref>
      <ref id="B21">
        <label>21.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kiritoshi</surname><given-names>T</given-names></name><name><surname>Ji</surname><given-names>G</given-names></name><name><surname>Neugebauer</surname><given-names>V</given-names></name></person-group>. <article-title>Rescue of impaired mGluR5-driven endocannabinoid signaling restores prefrontal cortical output to inhibit pain in arthritic rats</article-title>. <source>J Neurosci.</source> (<year>2016</year>) <volume>36</volume>:<fpage>837</fpage>–<lpage>50</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.4047-15.2016</pub-id><pub-id pub-id-type="pmid">26791214</pub-id></mixed-citation>
      </ref>
      <ref id="B22">
        <label>22.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ji</surname><given-names>G</given-names></name><name><surname>Neugebauer</surname><given-names>V</given-names></name></person-group>. <article-title>CB1 augments mGluR5 function in medial prefrontal cortical neurons to inhibit amygdala hyperactivity in an arthritis pain model</article-title>. <source>Eur J Neurosci.</source> (<year>2014</year>) <volume>39</volume>:<fpage>455</fpage>–<lpage>66</lpage>. <pub-id pub-id-type="doi">10.1111/ejn.12432</pub-id><pub-id pub-id-type="pmid">24494685</pub-id></mixed-citation>
      </ref>
      <ref id="B23">
        <label>23.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ji</surname><given-names>G</given-names></name><name><surname>Sun</surname><given-names>H</given-names></name><name><surname>Fu</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Pais-Vieira</surname><given-names>M</given-names></name><name><surname>Galhardo</surname><given-names>V</given-names></name><etal/></person-group>. <article-title>Cognitive impairment in pain through amygdala-driven prefrontal cortical deactivation</article-title>. <source>J Neurosci.</source> (<year>2010</year>) <volume>30</volume>:<fpage>5451</fpage>–<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.0225-10.2010</pub-id><pub-id pub-id-type="pmid">20392966</pub-id></mixed-citation>
      </ref>
      <ref id="B24">
        <label>24.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhai</surname><given-names>G</given-names></name><name><surname>Randell</surname><given-names>EW</given-names></name><name><surname>Rahman</surname><given-names>P</given-names></name></person-group>. <article-title>Metabolomics of osteoarthritis: emerging novel markers and their potential clinical utility</article-title>. <source>Rheumatology.</source> (<year>2018</year>) <volume>57</volume>:<fpage>2087</fpage>–<lpage>95</lpage>. <pub-id pub-id-type="doi">10.1093/rheumatology/kex497</pub-id><pub-id pub-id-type="pmid">29373736</pub-id></mixed-citation>
      </ref>
      <ref id="B25">
        <label>25.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Showiheen</surname><given-names>SAA</given-names></name><name><surname>Sun</surname><given-names>AR</given-names></name><name><surname>Wu</surname><given-names>X</given-names></name><name><surname>Crawford</surname><given-names>R</given-names></name><name><surname>Xiao</surname><given-names>Y</given-names></name><name><surname>Wellard</surname><given-names>RM</given-names></name><etal/></person-group>. <article-title>Application of metabolomics to osteoarthritis: from basic science to the clinical approach</article-title>. <source>Curr Rheumatol Rep.</source> (<year>2019</year>) <volume>21</volume>:<fpage>26</fpage>. <pub-id pub-id-type="doi">10.1007/s11926-019-0827-8</pub-id><pub-id pub-id-type="pmid">31062102</pub-id></mixed-citation>
      </ref>
      <ref id="B26">
        <label>26.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tootsi</surname><given-names>K</given-names></name><name><surname>Vilba</surname><given-names>K</given-names></name><name><surname>Martson</surname><given-names>A</given-names></name><name><surname>Kals</surname><given-names>J</given-names></name><name><surname>Paapstel</surname><given-names>K</given-names></name><name><surname>Zilmer</surname><given-names>M</given-names></name></person-group>. <article-title>Metabolomic signature of amino acids, biogenic amines and lipids in blood serum of patients with severe osteoarthritis</article-title>. <source>Metabolites</source>. (<year>2020</year>) <volume>10</volume>:<fpage>323</fpage>. <pub-id pub-id-type="doi">10.3390/metabo10080323</pub-id><pub-id pub-id-type="pmid">32784380</pub-id></mixed-citation>
      </ref>
      <ref id="B27">
        <label>27.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abdelrazig</surname><given-names>S</given-names></name><name><surname>Ortori</surname><given-names>CA</given-names></name><name><surname>Doherty</surname><given-names>M</given-names></name><name><surname>Valdes</surname><given-names>AM</given-names></name><name><surname>Chapman</surname><given-names>V</given-names></name><name><surname>Barrett</surname><given-names>DA</given-names></name></person-group>. <article-title>Metabolic signatures of osteoarthritis in urine using liquid chromatography-high resolution tandem mass spectrometry</article-title>. <source>Metabolomics.</source> (<year>2021</year>) <volume>17</volume>:<fpage>29</fpage>. <pub-id pub-id-type="doi">10.1007/s11306-021-01778-3</pub-id><pub-id pub-id-type="pmid">33655418</pub-id></mixed-citation>
      </ref>
      <ref id="B28">
        <label>28.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Likhodii</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Aref-Eshghi</surname><given-names>E</given-names></name><name><surname>Harper</surname><given-names>PE</given-names></name><name><surname>Randell</surname><given-names>E</given-names></name><etal/></person-group>. <article-title>Classification of osteoarthritis phenotypes by metabolomics analysis</article-title>. <source>BMJ Open.</source> (<year>2014</year>) <volume>4</volume>:<fpage>e006286</fpage>. <pub-id pub-id-type="doi">10.1136/bmjopen-2014-006286</pub-id><pub-id pub-id-type="pmid">25410606</pub-id></mixed-citation>
      </ref>
      <ref id="B29">
        <label>29.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mickiewicz</surname><given-names>B</given-names></name><name><surname>Kelly</surname><given-names>JJ</given-names></name><name><surname>Ludwig</surname><given-names>TE</given-names></name><name><surname>Weljie</surname><given-names>AM</given-names></name><name><surname>Wiley</surname><given-names>JP</given-names></name><name><surname>Schmidt</surname><given-names>TA</given-names></name><etal/></person-group>. <article-title>Metabolic analysis of knee synovial fluid as a potential diagnostic approach for osteoarthritis</article-title>. <source>J Orthop Res.</source> (<year>2015</year>) <volume>33</volume>:<fpage>1631</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1002/jor.22949</pub-id><pub-id pub-id-type="pmid">26010167</pub-id></mixed-citation>
      </ref>
      <ref id="B30">
        <label>30.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yue</surname><given-names>C</given-names></name><name><surname>Zou</surname><given-names>L</given-names></name><name><surname>Mei</surname><given-names>J</given-names></name><name><surname>Moore</surname><given-names>D</given-names></name><name><surname>Herold</surname><given-names>F</given-names></name><name><surname>Muller</surname><given-names>P</given-names></name><etal/></person-group>. <article-title>Tai chi training evokes significant changes in brain white matter network in older women</article-title>. <source>Healthcare</source>. (<year>2020</year>) <volume>8</volume>:<fpage>10057</fpage>. <pub-id pub-id-type="doi">10.3390/healthcare8010057</pub-id><pub-id pub-id-type="pmid">32182844</pub-id></mixed-citation>
      </ref>
      <ref id="B31">
        <label>31.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tao</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Egorova</surname><given-names>N</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Sun</surname><given-names>S</given-names></name><name><surname>Xue</surname><given-names>X</given-names></name><etal/></person-group>. <article-title>Increased hippocampus-medial prefrontal cortex resting-state functional connectivity and memory function after tai chi chuan practice in elder adults</article-title>. <source>Front Aging Neurosci.</source> (<year>2016</year>) <volume>8</volume>:<fpage>25</fpage>. <pub-id pub-id-type="doi">10.3389/fnagi.2016.00025</pub-id><pub-id pub-id-type="pmid">26909038</pub-id></mixed-citation>
      </ref>
      <ref id="B32">
        <label>32.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Apkarian</surname><given-names>AV</given-names></name><name><surname>Bushnell</surname><given-names>MC</given-names></name><name><surname>Treede</surname><given-names>RD</given-names></name><name><surname>Zubieta</surname><given-names>JK</given-names></name></person-group>. <article-title>Human brain mechanisms of pain perception and regulation in health and disease</article-title>. <source>Eur J Pain.</source> (<year>2005</year>) <volume>9</volume>:<fpage>463</fpage>–<lpage>84</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejpain.2004.11.001</pub-id><pub-id pub-id-type="pmid">15979027</pub-id></mixed-citation>
      </ref>
      <ref id="B33">
        <label>33.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thompson</surname><given-names>JM</given-names></name><name><surname>Neugebauer</surname><given-names>V</given-names></name></person-group>. <article-title>Cortico-limbic pain mechanisms</article-title>. <source>Neurosci Lett.</source> (<year>2019</year>) <volume>702</volume>:<fpage>15</fpage>–<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1016/j.neulet.2018.11.037</pub-id><pub-id pub-id-type="pmid">30503916</pub-id></mixed-citation>
      </ref>
      <ref id="B34">
        <label>34.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ong</surname><given-names>WY</given-names></name><name><surname>Stohler</surname><given-names>CS</given-names></name><name><surname>Herr</surname><given-names>DR</given-names></name></person-group>. <article-title>Role of the prefrontal cortex in pain processing</article-title>. <source>Mol Neurobiol.</source> (<year>2019</year>) <volume>56</volume>:<fpage>1137</fpage>–<lpage>66</lpage>. <pub-id pub-id-type="doi">10.1007/s12035-018-1130-9</pub-id><pub-id pub-id-type="pmid">29876878</pub-id></mixed-citation>
      </ref>
      <ref id="B35">
        <label>35.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Zong</surname><given-names>B</given-names></name><name><surname>Zhao</surname><given-names>W</given-names></name><name><surname>Li</surname><given-names>L</given-names></name></person-group>. <article-title>Effects of mind-body exercise on brain structure and function: a systematic review on MRI studies</article-title>. <source>Brain Sci</source>. (<year>2021</year>) <volume>11</volume>:<fpage>20205</fpage>. <pub-id pub-id-type="doi">10.3390/brainsci11020205</pub-id><pub-id pub-id-type="pmid">33562412</pub-id></mixed-citation>
      </ref>
      <ref id="B36">
        <label>36.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kober</surname><given-names>H</given-names></name><name><surname>Buhle</surname><given-names>J</given-names></name><name><surname>Weber</surname><given-names>J</given-names></name><name><surname>Ochsner</surname><given-names>KN</given-names></name><name><surname>Wager</surname><given-names>TD</given-names></name></person-group>. <article-title>Let it be: mindful acceptance down-regulates pain and negative emotion</article-title>. <source>Soc Cogn Affect Neurosci.</source> (<year>2019</year>) <volume>14</volume>:<fpage>1147</fpage>–<lpage>58</lpage>. <pub-id pub-id-type="doi">10.1093/scan/nsz104</pub-id><pub-id pub-id-type="pmid">31989171</pub-id></mixed-citation>
      </ref>
      <ref id="B37">
        <label>37.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Felson</surname><given-names>DT</given-names></name><name><surname>Naimark</surname><given-names>A</given-names></name><name><surname>Anderson</surname><given-names>J</given-names></name><name><surname>Kazis</surname><given-names>L</given-names></name><name><surname>Castelli</surname><given-names>W</given-names></name><name><surname>Meenan</surname><given-names>RF</given-names></name></person-group>. <article-title>The prevalence of knee osteoarthritis in the elderly. The Framingham Osteoarthritis Study</article-title>. <source>Arthritis Rheum.</source> (<year>1987</year>) <volume>30</volume>:<fpage>914</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1002/art.1780300811</pub-id><pub-id pub-id-type="pmid">3632732</pub-id></mixed-citation>
      </ref>
      <ref id="B38">
        <label>38.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peat</surname><given-names>G</given-names></name><name><surname>Thomas</surname><given-names>E</given-names></name><name><surname>Duncan</surname><given-names>R</given-names></name><name><surname>Wood</surname><given-names>L</given-names></name><name><surname>Hay</surname><given-names>E</given-names></name><name><surname>Croft</surname><given-names>P</given-names></name></person-group>. <article-title>Clinical classification criteria for knee osteoarthritis: performance in the general population and primary care</article-title>. <source>Ann Rheum Dis.</source> (<year>2006</year>) <volume>65</volume>:<fpage>1363</fpage>–<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1136/ard.2006.051482</pub-id><pub-id pub-id-type="pmid">16627539</pub-id></mixed-citation>
      </ref>
      <ref id="B39">
        <label>39.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Collet</surname><given-names>JP</given-names></name><name><surname>Lau</surname><given-names>J</given-names></name></person-group>. <article-title>The effect of Tai Chi on health outcomes in patients with chronic conditions: a systematic review</article-title>. <source>Arch Intern Med.</source> (<year>2004</year>) <volume>164</volume>:<fpage>493</fpage>–<lpage>501</lpage>. <pub-id pub-id-type="doi">10.1001/archinte.164.5.493</pub-id><pub-id pub-id-type="pmid">15006825</pub-id></mixed-citation>
      </ref>
      <ref id="B40">
        <label>40.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>CL</given-names></name><name><surname>Chyu</surname><given-names>MC</given-names></name><name><surname>Pence</surname><given-names>BC</given-names></name><name><surname>Yeh</surname><given-names>JK</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Felton</surname><given-names>CK</given-names></name><etal/></person-group>. <article-title>Green tea polyphenols supplementation and Tai Chi exercise for postmenopausal osteopenic women: safety and quality of life report</article-title>. <source>BMC Complement Altern Med.</source> (<year>2010</year>) <volume>10</volume>:<fpage>76</fpage>. <pub-id pub-id-type="doi">10.1186/1472-6882-10-76</pub-id><pub-id pub-id-type="pmid">21143878</pub-id></mixed-citation>
      </ref>
      <ref id="B41">
        <label>41.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>CL</given-names></name><name><surname>Chyu</surname><given-names>MC</given-names></name><name><surname>Yeh</surname><given-names>JK</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Pence</surname><given-names>BC</given-names></name><name><surname>Felton</surname><given-names>CK</given-names></name><etal/></person-group>. <article-title>Effect of green tea and Tai Chi on bone health in postmenopausal osteopenic women: a 6-month randomized placebo-controlled trial</article-title>. <source>Osteoporos Int.</source> (<year>2012</year>) <volume>23</volume>:<fpage>1541</fpage>–<lpage>52</lpage>. <pub-id pub-id-type="doi">10.1007/s00198-011-1731-x</pub-id><pub-id pub-id-type="pmid">21766228</pub-id></mixed-citation>
      </ref>
      <ref id="B42">
        <label>42.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>CL</given-names></name><name><surname>James</surname><given-names>CR</given-names></name><name><surname>Chyu</surname><given-names>MC</given-names></name><name><surname>Bixby</surname><given-names>WR</given-names></name><name><surname>Brismee</surname><given-names>JM</given-names></name><name><surname>Zumwalt</surname><given-names>MA</given-names></name><etal/></person-group>. <article-title>Effects of Tai Chi on gait kinematics, physical function, and pain in elderly with knee osteoarthritis–a pilot study</article-title>. <source>Am J Chin Med.</source> (<year>2008</year>) <volume>36</volume>:<fpage>219</fpage>–<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1142/S0192415X08005734</pub-id><pub-id pub-id-type="pmid">18457357</pub-id></mixed-citation>
      </ref>
      <ref id="B43">
        <label>43.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kapstad</surname><given-names>H</given-names></name><name><surname>Hanestad</surname><given-names>BR</given-names></name><name><surname>Langeland</surname><given-names>N</given-names></name><name><surname>Rustoen</surname><given-names>T</given-names></name><name><surname>Stavem</surname><given-names>K</given-names></name></person-group>. <article-title>Cutpoints for mild, moderate and severe pain in patients with osteoarthritis of the hip or knee ready for joint replacement surgery</article-title>. <source>BMC Musculoskelet Disord.</source> (<year>2008</year>) <volume>9</volume>:<fpage>55</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2474-9-55</pub-id><pub-id pub-id-type="pmid">18426591</pub-id></mixed-citation>
      </ref>
      <ref id="B44">
        <label>44.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roos</surname><given-names>EM</given-names></name><name><surname>Klassbo</surname><given-names>M</given-names></name><name><surname>Lohmander</surname><given-names>LS</given-names></name></person-group>. <article-title>WOMAC osteoarthritis index. Reliability, validity, and responsiveness in patients with arthroscopically assessed osteoarthritis Western Ontario and MacMaster Universities</article-title>. <source>Scand J Rheumatol.</source> (<year>1999</year>) <volume>28</volume>:<fpage>210</fpage>–<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1080/03009749950155562</pub-id><pub-id pub-id-type="pmid">10503556</pub-id></mixed-citation>
      </ref>
      <ref id="B45">
        <label>45.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsieh</surname><given-names>RL</given-names></name><name><surname>Lee</surname><given-names>WC</given-names></name><name><surname>Lo</surname><given-names>MT</given-names></name><name><surname>Liao</surname><given-names>WC</given-names></name></person-group>. <article-title>Postural stability in patients with knee osteoarthritis: comparison with controls and evaluation of relationships between postural stability scores and International Classification of Functioning, Disability and Health components</article-title>. <source>Arch Phys Med Rehabil.</source> (<year>2013</year>) <volume>94</volume>:<fpage>340</fpage>–<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1016/j.apmr.2012.09.022</pub-id><pub-id pub-id-type="pmid">23041145</pub-id></mixed-citation>
      </ref>
      <ref id="B46">
        <label>46.</label>
        <mixed-citation publication-type="webpage"><person-group person-group-type="author"><collab>Team RC</collab></person-group>. <source>A Language Environment for Statistical Computing. R Foundation for Statistical Computing</source> (<year>2019</year>). Available online at: <ext-link xlink:href="https://www.R-project.org/" ext-link-type="uri">https://www.R-project.org/</ext-link> (accessed September 10, 2021).</mixed-citation>
      </ref>
      <ref id="B47">
        <label>47.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rorden</surname><given-names>C</given-names></name><name><surname>Brett</surname><given-names>M</given-names></name></person-group>. <article-title>Stereotaxic display of brain lesions</article-title>. <source>Behav Neurol.</source> (<year>2000</year>) <volume>12</volume>:<fpage>191</fpage>–<lpage>200</lpage>. <pub-id pub-id-type="doi">10.1155/2000/421719</pub-id><pub-id pub-id-type="pmid">11568431</pub-id></mixed-citation>
      </ref>
      <ref id="B48">
        <label>48.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dale</surname><given-names>AM</given-names></name><name><surname>Fischl</surname><given-names>B</given-names></name><name><surname>Sereno</surname><given-names>MI</given-names></name></person-group>. <article-title>Cortical surface-based analysis. I. Segmentation and surface reconstruction</article-title>. <source>Neuroimage.</source> (<year>1999</year>) <volume>9</volume>:<fpage>179</fpage>–<lpage>94</lpage>. <pub-id pub-id-type="doi">10.1006/nimg.1998.0395</pub-id><pub-id pub-id-type="pmid">9931268</pub-id></mixed-citation>
      </ref>
      <ref id="B49">
        <label>49.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fischl</surname><given-names>B</given-names></name><name><surname>Salat</surname><given-names>DH</given-names></name><name><surname>van der Kouwe</surname><given-names>AJ</given-names></name><name><surname>Makris</surname><given-names>N</given-names></name><name><surname>Segonne</surname><given-names>F</given-names></name><name><surname>Quinn</surname><given-names>BT</given-names></name><etal/></person-group>. <article-title>Sequence-independent segmentation of magnetic resonance images</article-title>. <source>Neuroimage.</source> (<year>2004</year>) <volume>23</volume>(<issue>Suppl.1</issue>):<fpage>S69</fpage>–<lpage>84</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroimage.2004.07.016</pub-id><pub-id pub-id-type="pmid">15501102</pub-id></mixed-citation>
      </ref>
      <ref id="B50">
        <label>50.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jenkinson</surname><given-names>M</given-names></name><name><surname>Bannister</surname><given-names>P</given-names></name><name><surname>Brady</surname><given-names>M</given-names></name><name><surname>Smith</surname><given-names>S</given-names></name></person-group>. <article-title>Improved optimization for the robust and accurate linear registration and motion correction of brain images</article-title>. <source>Neuroimage.</source> (<year>2002</year>) <volume>17</volume>:<fpage>825</fpage>–<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1006/nimg.2002.1132</pub-id><pub-id pub-id-type="pmid">12377157</pub-id></mixed-citation>
      </ref>
      <ref id="B51">
        <label>51.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>SM</given-names></name></person-group>. <article-title>Fast robust automated brain extraction</article-title>. <source>Hum Brain Mapp.</source> (<year>2002</year>) <volume>17</volume>:<fpage>143</fpage>–<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1002/hbm.10062</pub-id><pub-id pub-id-type="pmid">12391568</pub-id></mixed-citation>
      </ref>
      <ref id="B52">
        <label>52.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jenkinson</surname><given-names>M</given-names></name><name><surname>Smith</surname><given-names>S</given-names></name></person-group>. <article-title>A global optimisation method for robust affine registration of brain images</article-title>. <source>Med Image Anal.</source> (<year>2001</year>) <volume>5</volume>:<fpage>143</fpage>–<lpage>56</lpage>. <pub-id pub-id-type="doi">10.1016/S1361-8415(01)00036-6</pub-id><pub-id pub-id-type="pmid">11516708</pub-id></mixed-citation>
      </ref>
      <ref id="B53">
        <label>53.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woolrich</surname><given-names>MW</given-names></name><name><surname>Ripley</surname><given-names>BD</given-names></name><name><surname>Brady</surname><given-names>M</given-names></name><name><surname>Smith</surname><given-names>SM</given-names></name></person-group>. <article-title>Temporal autocorrelation in univariate linear modeling of FMRI data</article-title>. <source>Neuroimage.</source> (<year>2001</year>) <volume>14</volume>:<fpage>1370</fpage>–<lpage>86</lpage>. <pub-id pub-id-type="doi">10.1006/nimg.2001.0931</pub-id><pub-id pub-id-type="pmid">11707093</pub-id></mixed-citation>
      </ref>
      <ref id="B54">
        <label>54.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carrasquillo</surname><given-names>Y</given-names></name><name><surname>Gereau</surname><given-names>RWt</given-names></name></person-group>. <article-title>Hemispheric lateralization of a molecular signal for pain modulation in the amygdala</article-title>. <source>Mol Pain.</source> (<year>2008</year>) <volume>4</volume>:<fpage>24</fpage>. <pub-id pub-id-type="doi">10.1186/1744-8069-4-24</pub-id><pub-id pub-id-type="pmid">18573207</pub-id></mixed-citation>
      </ref>
      <ref id="B55">
        <label>55.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ji</surname><given-names>G</given-names></name><name><surname>Neugebauer</surname><given-names>V</given-names></name></person-group>. <article-title>Hemispheric lateralization of pain processing by amygdala neurons</article-title>. <source>J Neurophysiol.</source> (<year>2009</year>) <volume>102</volume>:<fpage>2253</fpage>–<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1152/jn.00166.2009</pub-id><pub-id pub-id-type="pmid">19625541</pub-id></mixed-citation>
      </ref>
      <ref id="B56">
        <label>56.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nation</surname><given-names>KM</given-names></name><name><surname>De Felice</surname><given-names>M</given-names></name><name><surname>Hernandez</surname><given-names>PI</given-names></name><name><surname>Dodick</surname><given-names>DW</given-names></name><name><surname>Neugebauer</surname><given-names>V</given-names></name><name><surname>Navratilova</surname><given-names>E</given-names></name><etal/></person-group>. <article-title>Lateralized kappa opioid receptor signaling from the amygdala central nucleus promotes stress-induced functional pain</article-title>. <source>Pain.</source> (<year>2018</year>) <volume>159</volume>:<fpage>919</fpage>–<lpage>28</lpage>. <pub-id pub-id-type="doi">10.1097/j.pain.0000000000001167</pub-id><pub-id pub-id-type="pmid">29369967</pub-id></mixed-citation>
      </ref>
      <ref id="B57">
        <label>57.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Navratilova</surname><given-names>E</given-names></name><name><surname>Nation</surname><given-names>K</given-names></name><name><surname>Remeniuk</surname><given-names>B</given-names></name><name><surname>Neugebauer</surname><given-names>V</given-names></name><name><surname>Bannister</surname><given-names>K</given-names></name><name><surname>Dickenson</surname><given-names>AH</given-names></name><etal/></person-group>. <article-title>Selective modulation of tonic aversive qualities of neuropathic pain by morphine in the central nucleus of the amygdala requires endogenous opioid signaling in the anterior cingulate cortex</article-title>. <source>Pain.</source> (<year>2020</year>) <volume>161</volume>:<fpage>609</fpage>–<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1097/j.pain.0000000000001748</pub-id><pub-id pub-id-type="pmid">31725062</pub-id></mixed-citation>
      </ref>
      <ref id="B58">
        <label>58.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Phelps</surname><given-names>CE</given-names></name><name><surname>Navratilova</surname><given-names>E</given-names></name><name><surname>Dickenson</surname><given-names>AH</given-names></name><name><surname>Porreca</surname><given-names>F</given-names></name><name><surname>Bannister</surname><given-names>K</given-names></name></person-group>. <article-title>Kappa opioid signaling in the right central amygdala causes hind paw specific loss of diffuse noxious inhibitory controls in experimental neuropathic pain</article-title>. <source>Pain.</source> (<year>2019</year>) <volume>160</volume>:<fpage>1614</fpage>–<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1097/j.pain.0000000000001553</pub-id><pub-id pub-id-type="pmid">30870321</pub-id></mixed-citation>
      </ref>
      <ref id="B59">
        <label>59.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goncalves</surname><given-names>L</given-names></name><name><surname>Dickenson</surname><given-names>AH</given-names></name></person-group>. <article-title>Asymmetric time-dependent activation of right central amygdala neurones in rats with peripheral neuropathy and pregabalin modulation</article-title>. <source>Eur J Neurosci.</source> (<year>2012</year>) <volume>36</volume>:<fpage>3204</fpage>–<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1111/j.1460-9568.2012.08235.x</pub-id><pub-id pub-id-type="pmid">22861166</pub-id></mixed-citation>
      </ref>
      <ref id="B60">
        <label>60.</label>
        <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Andersson</surname><given-names>MJ</given-names></name><name><surname>Smith</surname><given-names>S</given-names></name></person-group>. <source>Non-linear registration, aka Spatial normalisation FMRIB technical report TR07JA2: FMRIB Analysis Group of the University of Oxford.</source>
<publisher-loc>Oxford</publisher-loc>: <publisher-name>Oxford University</publisher-name> (<year>2007</year>).</mixed-citation>
      </ref>
      <ref id="B61">
        <label>61.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheriyan</surname><given-names>J</given-names></name><name><surname>Kaushik</surname><given-names>MK</given-names></name><name><surname>Ferreira</surname><given-names>AN</given-names></name><name><surname>Sheets</surname><given-names>PL</given-names></name></person-group>. <article-title>Specific targeting of the basolateral amygdala to projectionally defined pyramidal neurons in prelimbic and infralimbic cortex</article-title>. <source>eNeuro</source>. (<year>2016</year>) <volume>3</volume>:<fpage>2016</fpage>. <pub-id pub-id-type="doi">10.1523/ENEURO.0002-16.2016</pub-id><pub-id pub-id-type="pmid">27022632</pub-id></mixed-citation>
      </ref>
      <ref id="B62">
        <label>62.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jensen</surname><given-names>KB</given-names></name><name><surname>Loitoile</surname><given-names>R</given-names></name><name><surname>Kosek</surname><given-names>E</given-names></name><name><surname>Petzke</surname><given-names>F</given-names></name><name><surname>Carville</surname><given-names>S</given-names></name><name><surname>Fransson</surname><given-names>P</given-names></name><etal/></person-group>. <article-title>Patients with fibromyalgia display less functional connectivity in the brain's pain inhibitory network</article-title>. <source>Mol Pain.</source> (<year>2012</year>) <volume>8</volume>:<fpage>32</fpage>. <pub-id pub-id-type="doi">10.1186/1744-8069-8-32</pub-id><pub-id pub-id-type="pmid">22537768</pub-id></mixed-citation>
      </ref>
      <ref id="B63">
        <label>63.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>Y</given-names></name><name><surname>Oathes</surname><given-names>D</given-names></name><name><surname>Hush</surname><given-names>J</given-names></name><name><surname>Darnall</surname><given-names>B</given-names></name><name><surname>Charvat</surname><given-names>M</given-names></name><name><surname>Mackey</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Perturbed connectivity of the amygdala and its subregions with the central executive and default mode networks in chronic pain</article-title>. <source>Pain.</source> (<year>2016</year>) <volume>157</volume>:<fpage>1970</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1097/j.pain.0000000000000606</pub-id><pub-id pub-id-type="pmid">27168362</pub-id></mixed-citation>
      </ref>
      <ref id="B64">
        <label>64.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vogt</surname><given-names>BA</given-names></name></person-group>. <article-title>Pain and emotion interactions in subregions of the cingulate gyrus</article-title>. <source>Nat Rev Neurosci.</source> (<year>2005</year>) <volume>6</volume>:<fpage>533</fpage>–<lpage>44</lpage>. <pub-id pub-id-type="doi">10.1038/nrn1704</pub-id><pub-id pub-id-type="pmid">15995724</pub-id></mixed-citation>
      </ref>
      <ref id="B65">
        <label>65.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Apkarian</surname><given-names>VA</given-names></name><name><surname>Hashmi</surname><given-names>JA</given-names></name><name><surname>Baliki</surname><given-names>MN</given-names></name></person-group>. <article-title>Pain and the brain: specificity and plasticity of the brain in clinical chronic pain</article-title>. <source>Pain</source>. (<year>2011</year>) <volume>152</volume>(<issue>3Suppl.</issue>):<fpage>S49</fpage>–<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1016/j.pain.2010.11.010</pub-id><pub-id pub-id-type="pmid">21146929</pub-id></mixed-citation>
      </ref>
      <ref id="B66">
        <label>66.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mumford</surname><given-names>J</given-names></name></person-group>. <article-title>A guide to calculating percent change with featquery</article-title>. <year>2007</year>.</mixed-citation>
      </ref>
      <ref id="B67">
        <label>67.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Behrens</surname><given-names>TE</given-names></name><name><surname>Woolrich</surname><given-names>MW</given-names></name><name><surname>Jenkinson</surname><given-names>M</given-names></name><name><surname>Johansen-Berg</surname><given-names>H</given-names></name><name><surname>Nunes</surname><given-names>RG</given-names></name><name><surname>Clare</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Characterization and propagation of uncertainty in diffusion-weighted MR imaging</article-title>. <source>Magn Reson Med.</source> (<year>2003</year>) <volume>50</volume>:<fpage>1077</fpage>–<lpage>88</lpage>. <pub-id pub-id-type="doi">10.1002/mrm.10609</pub-id><pub-id pub-id-type="pmid">14587019</pub-id></mixed-citation>
      </ref>
      <ref id="B68">
        <label>68.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woolrich</surname><given-names>MW</given-names></name><name><surname>Jbabdi</surname><given-names>S</given-names></name><name><surname>Patenaude</surname><given-names>B</given-names></name><name><surname>Chappell</surname><given-names>M</given-names></name><name><surname>Makni</surname><given-names>S</given-names></name><name><surname>Behrens</surname><given-names>T</given-names></name><etal/></person-group>. <article-title>Bayesian analysis of neuroimaging data in FSL</article-title>. <source>Neuroimage</source>. (<year>2009</year>) <volume>45</volume>(<issue>1Suppl.</issue>):<fpage>S173</fpage>–<lpage>86</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroimage.2008.10.055</pub-id><pub-id pub-id-type="pmid">19059349</pub-id></mixed-citation>
      </ref>
      <ref id="B69">
        <label>69.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Behrens</surname><given-names>TE</given-names></name><name><surname>Berg</surname><given-names>HJ</given-names></name><name><surname>Jbabdi</surname><given-names>S</given-names></name><name><surname>Rushworth</surname><given-names>MF</given-names></name><name><surname>Woolrich</surname><given-names>MW</given-names></name></person-group>. <article-title>Probabilistic diffusion tractography with multiple fibre orientations: what can we gain?</article-title>
<source>Neuroimage.</source> (<year>2007</year>) <volume>34</volume>:<fpage>144</fpage>–<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroimage.2006.09.018</pub-id><pub-id pub-id-type="pmid">17070705</pub-id></mixed-citation>
      </ref>
      <ref id="B70">
        <label>70.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thomas</surname><given-names>DM</given-names></name><name><surname>Clark</surname><given-names>N</given-names></name><name><surname>Turner</surname><given-names>D</given-names></name><name><surname>Siu</surname><given-names>C</given-names></name><name><surname>Halliday</surname><given-names>TM</given-names></name><name><surname>Hannon</surname><given-names>BA</given-names></name><etal/></person-group>. <article-title>Best (but oft-forgotten) practices: identifying and accounting for regression to the mean in nutrition and obesity research</article-title>. <source>Am J Clin Nutr.</source> (<year>2020</year>) <volume>111</volume>:<fpage>256</fpage>–<lpage>65</lpage>. <pub-id pub-id-type="doi">10.1093/ajcn/nqz196</pub-id><pub-id pub-id-type="pmid">31552422</pub-id></mixed-citation>
      </ref>
      <ref id="B71">
        <label>71.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bolyen</surname><given-names>E</given-names></name><name><surname>Rideout</surname><given-names>JR</given-names></name><name><surname>Dillon</surname><given-names>MR</given-names></name><name><surname>Bokulich</surname><given-names>NA</given-names></name><name><surname>Abnet</surname><given-names>CC</given-names></name><name><surname>Al-Ghalith</surname><given-names>GA</given-names></name><etal/></person-group>. <article-title>Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2</article-title>. <source>Nat Biotechnol.</source> (<year>2019</year>) <volume>37</volume>:<fpage>852</fpage>–<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1038/s41587-019-0209-9</pub-id><pub-id pub-id-type="pmid">31341288</pub-id></mixed-citation>
      </ref>
      <ref id="B72">
        <label>72.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pfannmoller</surname><given-names>J</given-names></name><name><surname>Lotze</surname><given-names>M</given-names></name></person-group>. <article-title>Review on biomarkers in the resting-state networks of chronic pain patients</article-title>. <source>Brain Cogn.</source> (<year>2019</year>) <volume>131</volume>:<fpage>4</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/j.bandc.2018.06.005</pub-id><pub-id pub-id-type="pmid">30879493</pub-id></mixed-citation>
      </ref>
      <ref id="B73">
        <label>73.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tootsi</surname><given-names>K</given-names></name><name><surname>Martson</surname><given-names>A</given-names></name><name><surname>Kals</surname><given-names>J</given-names></name><name><surname>Paapstel</surname><given-names>K</given-names></name><name><surname>Zilmer</surname><given-names>M</given-names></name></person-group>. <article-title>Metabolic factors and oxidative stress in osteoarthritis: a case-control study</article-title>. <source>Scand J Clin Lab Invest.</source> (<year>2017</year>) <volume>77</volume>:<fpage>520</fpage>–<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1080/00365513.2017.1354255</pub-id><pub-id pub-id-type="pmid">28737953</pub-id></mixed-citation>
      </ref>
      <ref id="B74">
        <label>74.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>R</given-names></name><name><surname>Han</surname><given-names>S</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>K</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>Perturbations in amino acids and metabolic pathways in osteoarthritis patients determined by targeted metabolomics analysis</article-title>. <source>J Chromatogr B Analyt Technol Biomed Life Sci.</source> (<year>2018</year>) <volume>1085</volume>:<fpage>54</fpage>–<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1016/j.jchromb.2018.03.047</pub-id><pub-id pub-id-type="pmid">29631251</pub-id></mixed-citation>
      </ref>
      <ref id="B75">
        <label>75.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Senol</surname><given-names>O</given-names></name><name><surname>Gundogdu</surname><given-names>G</given-names></name><name><surname>Gundogdu</surname><given-names>K</given-names></name><name><surname>Miloglu</surname><given-names>FD</given-names></name></person-group>. <article-title>Investigation of the relationships between knee osteoarthritis and obesity <italic toggle="yes">via</italic> untargeted metabolomics analysis</article-title>. <source>Clin Rheumatol.</source> (<year>2019</year>) <volume>38</volume>:<fpage>1351</fpage>–<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1007/s10067-019-04428-1</pub-id><pub-id pub-id-type="pmid">30637603</pub-id></mixed-citation>
      </ref>
      <ref id="B76">
        <label>76.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>G</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Chen</surname><given-names>T</given-names></name><name><surname>Zhu</surname><given-names>W</given-names></name><name><surname>Ding</surname><given-names>S</given-names></name><name><surname>Xu</surname><given-names>K</given-names></name><etal/></person-group>. <article-title>Metabolic analysis of osteoarthritis subchondral bone based on UPLC/Q-TOF-MS</article-title>. <source>Anal Bioanal Chem.</source> (<year>2016</year>) <volume>408</volume>:<fpage>4275</fpage>–<lpage>86</lpage>. <pub-id pub-id-type="doi">10.1007/s00216-016-9524-x</pub-id><pub-id pub-id-type="pmid">27074781</pub-id></mixed-citation>
      </ref>
      <ref id="B77">
        <label>77.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahmed</surname><given-names>U</given-names></name><name><surname>Anwar</surname><given-names>A</given-names></name><name><surname>Savage</surname><given-names>RS</given-names></name><name><surname>Costa</surname><given-names>ML</given-names></name><name><surname>Mackay</surname><given-names>N</given-names></name><name><surname>Filer</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Biomarkers of early stage osteoarthritis, rheumatoid arthritis and musculoskeletal health</article-title>. <source>Sci Rep.</source> (<year>2015</year>) <volume>5</volume>:<fpage>9259</fpage>. <pub-id pub-id-type="doi">10.1038/srep09259</pub-id><pub-id pub-id-type="pmid">25788417</pub-id></mixed-citation>
      </ref>
      <ref id="B78">
        <label>78.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pieretti</surname><given-names>S</given-names></name><name><surname>Di Giannuario</surname><given-names>A</given-names></name><name><surname>Di Giovannandrea</surname><given-names>R</given-names></name><name><surname>Marzoli</surname><given-names>F</given-names></name><name><surname>Piccaro</surname><given-names>G</given-names></name><name><surname>Minosi</surname><given-names>P</given-names></name><etal/></person-group>. <article-title>Gender differences in pain and its relief</article-title>. <source>Ann Ist Super Sanita.</source> (<year>2016</year>) <volume>52</volume>:<fpage>184</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.4415/ANN_16_02_09</pub-id><pub-id pub-id-type="pmid">27364392</pub-id></mixed-citation>
      </ref>
      <ref id="B79">
        <label>79.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rider</surname><given-names>JE</given-names></name><name><surname>Hacker</surname><given-names>A</given-names></name><name><surname>Mackintosh</surname><given-names>CA</given-names></name><name><surname>Pegg</surname><given-names>AE</given-names></name><name><surname>Woster</surname><given-names>PM</given-names></name><name><surname>Casero RA</surname><given-names>Jr</given-names></name></person-group>. <article-title>Spermine and spermidine mediate protection against oxidative damage caused by hydrogen peroxide</article-title>. <source>Amino Acids.</source> (<year>2007</year>) <volume>33</volume>:<fpage>231</fpage>–<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1007/s00726-007-0513-4</pub-id><pub-id pub-id-type="pmid">17396215</pub-id></mixed-citation>
      </ref>
      <ref id="B80">
        <label>80.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Brazill</surname><given-names>JM</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Bello</surname><given-names>C</given-names></name><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Morimoto</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Spermine synthase deficiency causes lysosomal dysfunction and oxidative stress in models of Snyder-Robinson syndrome</article-title>. <source>Nat Commun.</source> (<year>2017</year>) <volume>8</volume>:<fpage>1257</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-017-01289-7</pub-id><pub-id pub-id-type="pmid">29097652</pub-id></mixed-citation>
      </ref>
      <ref id="B81">
        <label>81.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qian</surname><given-names>G</given-names></name><name><surname>Xue</surname><given-names>K</given-names></name><name><surname>Tang</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>F</given-names></name><name><surname>Song</surname><given-names>X</given-names></name><name><surname>Chyu</surname><given-names>MC</given-names></name><etal/></person-group>. <article-title>Mitigation of oxidative damage by green tea polyphenols and Tai Chi exercise in postmenopausal women with osteopenia</article-title>. <source>PLoS ONE.</source> (<year>2012</year>) <volume>7</volume>:<fpage>e48090</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0048090</pub-id><pub-id pub-id-type="pmid">23118932</pub-id></mixed-citation>
      </ref>
      <ref id="B82">
        <label>82.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosado-Perez</surname><given-names>J</given-names></name><name><surname>Santiago-Osorio</surname><given-names>E</given-names></name><name><surname>Ortiz</surname><given-names>R</given-names></name><name><surname>Mendoza-Nunez</surname><given-names>VM</given-names></name></person-group>. <article-title>Tai chi diminishes oxidative stress in Mexican older adults</article-title>. <source>J Nutr Health Aging.</source> (<year>2012</year>) <volume>16</volume>:<fpage>642</fpage>–<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1007/s12603-012-0029-9</pub-id><pub-id pub-id-type="pmid">22836707</pub-id></mixed-citation>
      </ref>
      <ref id="B83">
        <label>83.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosado-Perez</surname><given-names>J</given-names></name><name><surname>Ortiz</surname><given-names>R</given-names></name><name><surname>Santiago-Osorio</surname><given-names>E</given-names></name><name><surname>Mendoza-Nunez</surname><given-names>VM</given-names></name></person-group>. <article-title>Effect of Tai Chi versus walking on oxidative stress in Mexican older adults</article-title>. <source>Oxid Med Cell Longev.</source> (<year>2013</year>) <volume>2013</volume>:<fpage>298590</fpage>. <pub-id pub-id-type="doi">10.1155/2013/298590</pub-id><pub-id pub-id-type="pmid">23936607</pub-id></mixed-citation>
      </ref>
      <ref id="B84">
        <label>84.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mendoza-Nunez</surname><given-names>VM</given-names></name><name><surname>Hernandez-Monjaraz</surname><given-names>B</given-names></name><name><surname>Santiago-Osorio</surname><given-names>E</given-names></name><name><surname>Betancourt-Rule</surname><given-names>JM</given-names></name><name><surname>Ruiz-Ramos</surname><given-names>M</given-names></name></person-group>. <article-title>Tai Chi exercise increases SOD activity and total antioxidant status in saliva and is linked to an improvement of periodontal disease in the elderly</article-title>. <source>Oxid Med Cell Longev.</source> (<year>2014</year>) <volume>2014</volume>:<fpage>603853</fpage>. <pub-id pub-id-type="doi">10.1155/2014/603853</pub-id><pub-id pub-id-type="pmid">24790703</pub-id></mixed-citation>
      </ref>
      <ref id="B85">
        <label>85.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mendoza-Nunez</surname><given-names>VM</given-names></name><name><surname>Arista-Ugalde</surname><given-names>TL</given-names></name><name><surname>Rosado-Perez</surname><given-names>J</given-names></name><name><surname>Ruiz-Ramos</surname><given-names>M</given-names></name><name><surname>Santiago-Osorio</surname><given-names>E</given-names></name></person-group>. <article-title>Hypoglycemic and antioxidant effect of Tai chi exercise training in older adults with metabolic syndrome</article-title>. <source>Clin Interv Aging.</source> (<year>2018</year>) <volume>13</volume>:<fpage>523</fpage>–<lpage>31</lpage>. <pub-id pub-id-type="doi">10.2147/CIA.S157584</pub-id><pub-id pub-id-type="pmid">29662308</pub-id></mixed-citation>
      </ref>
      <ref id="B86">
        <label>86.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neugebauer</surname><given-names>V</given-names></name></person-group>. <source>Serotonin – Pain Modulation. Handbook of the Behavioral Neurobiology of Serotonin. 2nd ed.</source> (<year>2020</year>). p. <fpage>309</fpage>–<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1016/B978-0-444-64125-0.00017-7</pub-id></mixed-citation>
      </ref>
      <ref id="B87">
        <label>87.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seidel</surname><given-names>MF</given-names></name><name><surname>Fiebich</surname><given-names>BL</given-names></name><name><surname>Ulrich-Merzenich</surname><given-names>G</given-names></name><name><surname>Candelario-Jalil</surname><given-names>E</given-names></name><name><surname>Koch</surname><given-names>FW</given-names></name><name><surname>Vetter</surname><given-names>H</given-names></name></person-group>. <article-title>Serotonin mediates PGE2 overexpression through 5-HT2A and 5-HT3 receptor subtypes in serum-free tissue culture of macrophage-like synovial cells</article-title>. <source>Rheumatol Int.</source> (<year>2008</year>) <volume>28</volume>:<fpage>1017</fpage>–<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1007/s00296-008-0564-1</pub-id><pub-id pub-id-type="pmid">18368410</pub-id></mixed-citation>
      </ref>
      <ref id="B88">
        <label>88.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ji</surname><given-names>G</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Mahimainathan</surname><given-names>L</given-names></name><name><surname>Narasimhan</surname><given-names>M</given-names></name><name><surname>Kiritoshi</surname><given-names>T</given-names></name><name><surname>Fan</surname><given-names>X</given-names></name><etal/></person-group>. <article-title>5-HT2C receptor knockdown in the amygdala inhibits neuropathic-pain-related plasticity and behaviors</article-title>. <source>J Neurosci.</source> (<year>2017</year>) <volume>37</volume>:<fpage>1378</fpage>–<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2468-16.2016</pub-id><pub-id pub-id-type="pmid">28011743</pub-id></mixed-citation>
      </ref>
      <ref id="B89">
        <label>89.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Logters</surname><given-names>TT</given-names></name><name><surname>Laryea</surname><given-names>MD</given-names></name><name><surname>Jager</surname><given-names>M</given-names></name><name><surname>Schadel-Hopfner</surname><given-names>M</given-names></name><name><surname>Windolf</surname><given-names>J</given-names></name><name><surname>Flohe</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Kynurenine inhibits chondrocyte proliferation and is increased in synovial fluid of patients with septic arthritis</article-title>. <source>J Orthop Res.</source> (<year>2010</year>) <volume>28</volume>:<fpage>1490</fpage>–<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1002/jor.21158</pub-id><pub-id pub-id-type="pmid">20872586</pub-id></mixed-citation>
      </ref>
      <ref id="B90">
        <label>90.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kelly</surname><given-names>S</given-names></name><name><surname>Chapman</surname><given-names>RJ</given-names></name><name><surname>Woodhams</surname><given-names>S</given-names></name><name><surname>Sagar</surname><given-names>DR</given-names></name><name><surname>Turner</surname><given-names>J</given-names></name><name><surname>Burston</surname><given-names>JJ</given-names></name><etal/></person-group>. <article-title>Increased function of pronociceptive TRPV1 at the level of the joint in a rat model of osteoarthritis pain</article-title>. <source>Ann Rheum Dis.</source> (<year>2015</year>) <volume>74</volume>:<fpage>252</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1136/annrheumdis-2013-203413</pub-id><pub-id pub-id-type="pmid">24152419</pub-id></mixed-citation>
      </ref>
      <ref id="B91">
        <label>91.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galindo</surname><given-names>T</given-names></name><name><surname>Reyna</surname><given-names>J</given-names></name><name><surname>Weyer</surname><given-names>A</given-names></name></person-group>. <article-title>Evidence for transient receptor potential (TRP) channel contribution to arthritis pain and pathogenesis</article-title>. <source>Pharmaceuticals</source>. (<year>2018</year>) <volume>11</volume>:<fpage>40105</fpage>. <pub-id pub-id-type="doi">10.3390/ph11040105</pub-id><pub-id pub-id-type="pmid">30326593</pub-id></mixed-citation>
      </ref>
      <ref id="B92">
        <label>92.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>JR</given-names></name><name><surname>Chokesuwattanaskul</surname><given-names>S</given-names></name><name><surname>Phelan</surname><given-names>MM</given-names></name><name><surname>Welting</surname><given-names>TJM</given-names></name><name><surname>Lian</surname><given-names>LY</given-names></name><name><surname>Peffers</surname><given-names>MJ</given-names></name><etal/></person-group>. <article-title>(1)H NMR metabolomics identifies underlying inflammatory pathology in osteoarthritis and rheumatoid arthritis synovial joints</article-title>. <source>J Proteome Res.</source> (<year>2018</year>) <volume>17</volume>:<fpage>3780</fpage>–<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jproteome.8b00455</pub-id><pub-id pub-id-type="pmid">30229649</pub-id></mixed-citation>
      </ref>
      <ref id="B93">
        <label>93.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caterina</surname><given-names>MJ</given-names></name><name><surname>Schumacher</surname><given-names>MA</given-names></name><name><surname>Tominaga</surname><given-names>M</given-names></name><name><surname>Rosen</surname><given-names>TA</given-names></name><name><surname>Levine</surname><given-names>JD</given-names></name><name><surname>Julius</surname><given-names>D</given-names></name></person-group>. <article-title>The capsaicin receptor: a heat-activated ion channel in the pain pathway</article-title>. <source>Nature.</source> (<year>1997</year>) <volume>389</volume>:<fpage>816</fpage>–<lpage>24</lpage>. <pub-id pub-id-type="doi">10.1038/39807</pub-id><pub-id pub-id-type="pmid">9349813</pub-id></mixed-citation>
      </ref>
      <ref id="B94">
        <label>94.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jordt</surname><given-names>SE</given-names></name><name><surname>Tominaga</surname><given-names>M</given-names></name><name><surname>Julius</surname><given-names>D</given-names></name></person-group>. <article-title>Acid potentiation of the capsaicin receptor determined by a key extracellular site</article-title>. <source>Proc Natl Acad Sci USA.</source> (<year>2000</year>) <volume>97</volume>:<fpage>8134</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.100129497</pub-id><pub-id pub-id-type="pmid">10859346</pub-id></mixed-citation>
      </ref>
      <ref id="B95">
        <label>95.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gauldie</surname><given-names>SD</given-names></name><name><surname>McQueen</surname><given-names>DS</given-names></name><name><surname>Pertwee</surname><given-names>R</given-names></name><name><surname>Chessell</surname><given-names>IP</given-names></name></person-group>. <article-title>Anandamide activates peripheral nociceptors in normal and arthritic rat knee joints</article-title>. <source>Br J Pharmacol.</source> (<year>2001</year>) <volume>132</volume>:<fpage>617</fpage>–<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1038/sj.bjp.0703890</pub-id><pub-id pub-id-type="pmid">11159713</pub-id></mixed-citation>
      </ref>
      <ref id="B96">
        <label>96.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rimola</surname><given-names>V</given-names></name><name><surname>Hahnefeld</surname><given-names>L</given-names></name><name><surname>Zhao</surname><given-names>J</given-names></name><name><surname>Jiang</surname><given-names>C</given-names></name><name><surname>Angioni</surname><given-names>C</given-names></name><name><surname>Schreiber</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>Lysophospholipids contribute to oxaliplatin-induced acute peripheral pain</article-title>. <source>J Neurosci.</source> (<year>2020</year>) <volume>40</volume>:<fpage>9519</fpage>–<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1223-20.2020</pub-id><pub-id pub-id-type="pmid">33158961</pub-id></mixed-citation>
      </ref>
      <ref id="B97">
        <label>97.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koda</surname><given-names>K</given-names></name><name><surname>Hyakkoku</surname><given-names>K</given-names></name><name><surname>Ogawa</surname><given-names>K</given-names></name><name><surname>Takasu</surname><given-names>K</given-names></name><name><surname>Imai</surname><given-names>S</given-names></name><name><surname>Sakurai</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>Sensitization of TRPV1 by protein kinase C in rats with mono-iodoacetate-induced joint pain</article-title>. <source>Osteoarthritis Cartilage.</source> (<year>2016</year>) <volume>24</volume>:<fpage>1254</fpage>–<lpage>62</lpage>. <pub-id pub-id-type="doi">10.1016/j.joca.2016.02.010</pub-id><pub-id pub-id-type="pmid">26970286</pub-id></mixed-citation>
      </ref>
      <ref id="B98">
        <label>98.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gouin</surname><given-names>O</given-names></name><name><surname>L'Herondelle</surname><given-names>K</given-names></name><name><surname>Lebonvallet</surname><given-names>N</given-names></name><name><surname>Le Gall-Ianotto</surname><given-names>C</given-names></name><name><surname>Sakka</surname><given-names>M</given-names></name><name><surname>Buhe</surname><given-names>V</given-names></name><etal/></person-group>. <article-title>TRPV1 and TRPA1 in cutaneous neurogenic and chronic inflammation: pro-inflammatory response induced by their activation and their sensitization</article-title>. <source>Protein Cell.</source> (<year>2017</year>) <volume>8</volume>:<fpage>644</fpage>–<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1007/s13238-017-0395-5</pub-id><pub-id pub-id-type="pmid">28364279</pub-id></mixed-citation>
      </ref>
      <ref id="B99">
        <label>99.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tootsi</surname><given-names>K</given-names></name><name><surname>Kals</surname><given-names>J</given-names></name><name><surname>Zilmer</surname><given-names>M</given-names></name><name><surname>Paapstel</surname><given-names>K</given-names></name><name><surname>Ottas</surname><given-names>A</given-names></name><name><surname>Martson</surname><given-names>A</given-names></name></person-group>. <article-title>Medium- and long-chain acylcarnitines are associated with osteoarthritis severity and arterial stiffness in end-stage osteoarthritis patients: a case-control study</article-title>. <source>Int J Rheum Dis.</source> (<year>2018</year>) <volume>21</volume>:<fpage>1211</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1111/1756-185X.13251</pub-id><pub-id pub-id-type="pmid">29314768</pub-id></mixed-citation>
      </ref>
      <ref id="B100">
        <label>100.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosado-Perez</surname><given-names>J</given-names></name><name><surname>Castelan-Martinez</surname><given-names>OD</given-names></name><name><surname>Mujica-Calderon</surname><given-names>AJ</given-names></name><name><surname>Sanchez-Rodriguez</surname><given-names>MA</given-names></name><name><surname>Mendoza-Nunez</surname><given-names>VM</given-names></name></person-group>. <article-title>Effect of tai chi on markers of oxidative stress: systematic review and meta-analysis</article-title>. <source>Int J Environ Res Public Health</source>. (<year>2021</year>) <volume>18</volume>:<fpage>73458</fpage>. <pub-id pub-id-type="doi">10.3390/ijerph18073458</pub-id><pub-id pub-id-type="pmid">33810466</pub-id></mixed-citation>
      </ref>
      <ref id="B101">
        <label>101.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alenazi</surname><given-names>AM</given-names></name><name><surname>Alshehri</surname><given-names>MM</given-names></name><name><surname>Hoover</surname><given-names>JC</given-names></name><name><surname>Yabroudi</surname><given-names>MA</given-names></name><name><surname>Kachanathu</surname><given-names>SJ</given-names></name><name><surname>Liu</surname><given-names>W</given-names></name></person-group>. <article-title>The effect of t'ai chi exercise on lipid profiles: a systematic review and meta-analysis of randomized clinical trials</article-title>. <source>J Altern Complement Med.</source> (<year>2018</year>) <volume>24</volume>:<fpage>220</fpage>–<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1089/acm.2017.0104</pub-id><pub-id pub-id-type="pmid">28934556</pub-id></mixed-citation>
      </ref>
      <ref id="B102">
        <label>102.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pousinis</surname><given-names>P</given-names></name><name><surname>Gowler</surname><given-names>PRW</given-names></name><name><surname>Burston</surname><given-names>JJ</given-names></name><name><surname>Ortori</surname><given-names>CA</given-names></name><name><surname>Chapman</surname><given-names>V</given-names></name><name><surname>Barrett</surname><given-names>DA</given-names></name></person-group>. <article-title>Lipidomic identification of plasma lipids associated with pain behaviour and pathology in a mouse model of osteoarthritis</article-title>. <source>Metabolomics.</source> (<year>2020</year>) <volume>16</volume>:<fpage>32</fpage>. <pub-id pub-id-type="doi">10.1007/s11306-020-01652-8</pub-id><pub-id pub-id-type="pmid">32108917</pub-id></mixed-citation>
      </ref>
      <ref id="B103">
        <label>103.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Myers</surname><given-names>RA</given-names></name><name><surname>Plym</surname><given-names>MJ</given-names></name><name><surname>Signor</surname><given-names>LJ</given-names></name><name><surname>Lodge</surname><given-names>NJ</given-names></name></person-group>. <article-title>1-(2-pyrimidinyl)-piperazine, a buspirone metabolite, modulates bladder function in the anesthetized rat</article-title>. <source>Neurourol Urodyn.</source> (<year>2004</year>) <volume>23</volume>:<fpage>709</fpage>–<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1002/nau.20037</pub-id><pub-id pub-id-type="pmid">15382198</pub-id></mixed-citation>
      </ref>
      <ref id="B104">
        <label>104.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eklund</surname><given-names>A</given-names></name><name><surname>Nichols</surname><given-names>TE</given-names></name><name><surname>Knutsson</surname><given-names>H</given-names></name></person-group>. <article-title>Cluster failure: why fMRI inferences for spatial extent have inflated false-positive rates</article-title>. <source>Proc Natl Acad Sci USA.</source> (<year>2016</year>) <volume>113</volume>:<fpage>7900</fpage>–<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1602413113</pub-id><pub-id pub-id-type="pmid">27357684</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
